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Lay Summary
The generation of diversity is a hallmark of biological systems. In systems
causing disease, this diversity can have dire consequences. To understand this
universal feature, we must consider the processes that created it. Due to the
extraordinary complexity of biological systems, quantitative reasoning is required.
In this thesis, we adopt a mathematical approach and consider how diversity is
generated for idealised, conceptual models, developed under the motivation of
describing cancer. First, we characterise the expected sizes of clusters of cells,
when the clusters are offshoots from an originating cellular population. Second,
for a population of cells which can replicate and evolve, we enquire as to when,
and how, a particular type of cell emerges. The aim is to capture the essence of
the biological processes in our idealised models, understand the key quantities in




There is a growing appreciation for the insight mathematical models can yield on
biological systems. In particular, due to the challenges inherent in experimental
observation of disease progression, models describing the genesis, growth and
evolution of cancer have been developed. Many of these models possess the
common feature that one particular type of cellular population initiates a further,
distinct population. This thesis explores two models containing this feature,
which also employ branching processes to describe population growth.
Firstly, we consider a deterministically growing wild type population which
seeds stochastically developing mutant clones. This generalises the classic Luria-
Delbrück model of bacterial evolution. We focus on how differing wild type
growth manifests itself in the distribution of clone sizes. In our main result we
prove that for a large class of wild type growth, the long-time limit of the clone
size distribution has a general two-parameter form, whose tail decays as a power-
law.
In the second model, we consider a fully stochastic system of cells in a growing
population that can undergo birth, death and transitions. New cellular types
appear via transitions, examples of which are genetic mutations or migrations
bringing cells into a new environment. We concentrate on the scenario where the
original cell type has the largest net growth rate, which is relevant for modelling
drug resistance, due to fitness costs of resistance, or cells migrating into contact
with a toxin. Two questions are considered in our main results. First, how
long do we wait until a cell with a specific target type, an arbitrary number
of transitions from the original population, exists. Second, which particular
sequence of transitions initiated the target population. In the limit of small final
transition rates, simple, explicit formulas are given to answer these questions.
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2.1 The clone size generating function for special cases of the wild
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This thesis is concerned with populations of cells which seed further cellular
populations. The meaning of ‘seed’ is context dependent, but examples are
genetic mutations initiating a drug resistant subpopulation or cells migrating
into a new environment. Mathematical models to study such a scenario abound
[1, 13, 66], and have been applied to numerous settings including the emergence
of drug resistance [14, 57], inference on genomic data [16, 91], the initiation of
metastasis [25, 37] or microlesions [69] and the impact of poor drug penetration
[33, 36, 65]. Motivated by cancer, and bacterial and viral infections, we will focus
on the case where the populations under consideration grow, by which we mean,
increase in number over time.
Perhaps the prototypic biological example for the initiation of a growing popu-
lation from another is found in the Nobel prize winning work of microbiologist
Salvador Luria and theoretical physicist Max Delbrück [62]. Due its relevance
on this thesis, its simplicity and its profundity, we shall discuss this example
in some detail. The motivation for Luria and Delbrück’s work was discerning
the manner in which mutations arose in bacterial populations. At the time, it
was known that if a large population of bacteria (say 109 cells) was mixed with a
bactericidal toxin, a fraction of the bacteria often survived. Further, the offspring
of the surviving bacteria remained resistant, in the sense that they could survive
further exposure to the toxin. Two competing hypotheses existed to explain this
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phenomenon. The first, known as the adaption theory, proposed that, by some
unknown mechanism, upon exposure to the toxin individual bacterium could alter
their state, and this new state was heritable. In essence, population variation is
induced in response to the environment. The second hypothesis, known as the
mutation theory, posited that from a replication event, a bacterium with the
resistant state could arise spontaneously. It is worth noting that at the time it
was unknown even whether bacteria possessed a genome. An accessible historical
overview of these matters is given by Robbins in the foreword to [62] as part of
the electronic scholarly publishing project [72].
By combining theory and experiment, Luria and Delbrück provided the first
strong evidence for the mutation theory hypothesis. To do so, two idealised
models were proposed for the two hypotheses. For the adaption theory it was
supposed that each of the large number of bacteria, say N , independently adapted
upon exposure to the toxin with a small probability p. Therefore the number
of bacteria surviving exposure, known as the mutants, would be binomially
distributed with mean Np. In this case, the ratio of the variance to the mean
mutant number would be (1 − p), and so, for a small adaption probability the
mean and variance are approximately equal.
For the mutation theory hypothesis the following model was proposed. Starting
from an initial cell, the number of toxin sensitive bacteria (often referred to as
the wild type), say Ns(t), grow deterministically and exponentially. If mutation
events occur at the replication of sensitive bacteria, then in a short time interval
[t, t+dt], the chance of a mutation occurring should be proportional to the number
of sensitive cells, Ns(t) and the per replication mutation probability, say ν, which
is again assumed small. This defined when mutations occurred, and to complete
the model they supposed the mutant population grew in a similar fashion to the
sensitive cells.
The key insight is that, under the mutation theory, early mutation events are
relatively unlikely (as νNs(t) is small), however when they occur, the mutant
number will be large (as the mutant population has longer to exponentially grow).
Intuitively this results in a larger variance in the mutant number. Confirming this,
under their mutation model (as described in the previous paragraph), Delbrück
demonstrated that the ratio of the variance to the mean number of mutants
was approximately N/ logN (omitting prefactors also). N is again the total
population size when the toxin is added, and as it is assumed large, the variance
to mean number of mutants is considerably larger than 1 (as it was under the
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adaption theory model). This result will be given as a specific example in Chapter
2.
Each hypothesis gave a distinct outcome in terms of the relationship of the
mean and variance of the mutant numbers, and so it remained to experimentally
determine these quantities. By taking replicate cultures of bacteria, exposing
these to toxins, and counting the number of surviving mutant cells, Luria obtained
estimates of the mean and variance. The sample variance was found to be roughly
two orders of magnitude greater than the sample mean. This provided strong
evidence for the mutation theory, and resulted in a paradigm shift in the study
of bacteria [77].
Calculation of the mean and variance in the number of mutants was sufficient to
distinguish between the competing hypotheses in the work of Luria and Delbrück.
They also established the probability that no resistant bacteria would exist and
derived one of the first estimators of the mutation probability (the probability
of a resistance conferring mutation per cell division). However several questions
remained. The distribution of the number of mutants was unknown, as was the
effect of stochastic growth, cell death and non-neutral mutations (the mutant
populations grew at the same rate in [62]).
These extensions to the original Luria-Delbrück mutation theory model are
not simply mathematical curiosities. For example, knowledge of the mutant
distribution permits maximum likelihood estimation of the mutation probability,
which, within a Luria-Delbrück formalism, is the current state of the art
estimation method [74, 94]. As an aside, the event of interest need not be a
resistance conferring point mutation, the probability of gene amplifications per
cell replication has also been inferred using this framework [83]. While in the
setting of cancer, if a tumour of a fixed size is observed, neglecting cell death
leads to an underestimation of the probability of resistance. This is in turn due
to an underestimation of the number of replication events.
Thus a large effort has been made to understand the mutant distribution when
some or all of the extensions mentioned above are included [3, 7, 22, 46, 51, 53,
58, 60, 64, 93]. The level of rigor, techniques used, and applications of interest
vary across these works. The first breakthrough came from Lea and Coulson
[60] who introduced neutral, stochastic mutant growth but kept the wild type
growth deterministic. The most recent complete description is found in [5] who
deduced the exact solution of the mutant distribution at a finite time, while
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including all the previously mentioned extensions. Interestingly, in the often
biologically relevant regimes of large time/population size and small mutation
rate, the mutant distribution coincides with that given by a deterministically,
exponentially growing wild type population, although a random amplitude is
required in the time setting [16]. The meaning of ‘random amplitude’ will be
given later in this chapter.
Common to all the works discussed above is that on average the populations grow
exponentially. There are at least two reasons for this. Firstly, in the primary
applications, namely cancer and bacterial infections, growth often does appear
exponential, at least initially [8, 73]. Secondly, in many models, the exponential
growth arises from assuming cells behave independently, and this independence
offers far greater tractability. However due to environmental restrictions, e.g.
space limitation, exponential population growth cannot continue indefinitely. For
the types of questions considered thus far, moving away from the assumption of
exponential growth has received limited previous consideration, as discussed in
[31]. Introducing environmental restrictions may be accomplished in a variety of
manners, for example using logistic branching processes, but motivated by the
success of the semi-deterministic approach of Lea and Coulson discussed above a
first step could be to consider non-exponential but deterministic wild type growth.
This motivates the work presented in Chapter 2 of this thesis.
Note that the above discussion thus far has concerned the wild type population
seeding a secondary mutant population, where mutant cells are one transition
from the wild type. A natural extension is when the population of interest is
several transitions from the original population. This would be the scenario if
our interest is in multidrug resistance, where it is often necessary to have two
separate genes, coding for two target proteins, mutated. As in the setting with
only two populations, a standard question is: starting with a given number of
cells of the original population type, do cells of a given number of transitions
exist when the total population is observed at a later time or a given size?
For differing applications, the case of two transitions being required has been
treated in [14, 18, 38]. Motivated by the accumulation of driver mutations in
cancer, the time until an arbitrary number of transitions has occurred, when
each transition increases the reproductive potential of cells was given in [27].
An efficient numerical scheme coupled with an extensive biological discussion on
multidrug resistance was presented in [57] for an arbitrary number of neutral
transitions.
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However, the setting of transitions leading to a decrease in reproductive ability
within a growing population framework has not been fully considered. Exemplar
reasons for contemplating such a scenario are that acquiring resistance often
comes with a fitness ‘cost’ [2] and, interpreting transitions as migration events, the
effect of drugs on migrated, sensitive cells. When several transitions are required
for a cell type of interest to occur, a natural question is in which sequence do
these transitions occur? For example do cells acquire resistance to drug A then
B or vice versa. For varied biological scenarios this question has been considered
in [33, 41, 65]. However except for [65] only two transitions were required. We
attempt to address some of the questions indicated here in Chapter 3. It is worth
reiterating that we continue to focus on scenarios with population growth. Within
a fixed size population, the time until an arbitrary number of fitness reducing
transitions has been considered in [35, 89]. Similarly, again for an approximately
fixed size population, which sequence of transitions is most likely when transitions
reduce reproductive ability was computationally explored in [80], with phenotypic
switching the transitions of key interest.
Our introduction thus far has focused on models arising from biological appli-
cations. However many of these models are specific examples of the class of
stochastic processes known as branching processes [6]. The questions considered
in this thesis, for instance the large time small mutation limit discussed above, are
not standard in branching process theory. However it will be seen that the well
developed asymptotic theory [6, 47] provides useful tools with which to answer
biologically motivated questions.
Having provided motivation for the work presented in this thesis, we now give a
brief outline, detailing the contributions.
1.2 Thesis overview and summary of results
The outline of the remainder of this work is as follows. In the subsequent section
a short introduction to the linear birth death process, non-homogeneous Poisson
processes and Cox processes is given. Our reasoning for doing so is that these
mathematical objects are common to both central chapters of the thesis. We then
turn to the main content of this work.
In Chapter 2, similar to the classic setting of Luria and Delbrück, we consider
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wild type cells initiating a mutant population. It is near ubiquitous to assume
exponential growth of the wild type population and we investigate how deviations
from this assumption alter the process. While we continue to use the language of
wild-type/mutant cells, our main motivation is that of a primary tumour (wild-
type) seeding metastases (mutant clones). Due to this, differing from previous
studies, our interest is in the mutant clone size distribution, which represents the
distribution of metastases sizes in the cancer setting. Results regarding the clones
can be mapped to the total mutant number. In our main result we prove that
the large time limit of the clone size distribution has a general two-parameter
form for a large class of population growth. The limiting clone size distribution
always has a power-law tail, and for slower than exponential wild type growth
the probability of a given clone size is inversely proportional to the clone size.
We support our results by analysing a dataset on metastasis sizes, and we find
that a power-law tail is more likely than an exponential one, in agreement with
our predictions.
Turning to Chapter 3, as discussed above, motivated by numerous applications
we consider cells in a growing population that can undergo birth, death and
transitions. Transitions, which may affect the genotype or environment of the
cells, result in new cellular types. Motivated by the measured fitness cost of
resistance in bacteria and sensitive cells in contact with drugs, we focus on
the setting where the initial cellular type has the highest reproductive ability.
We answer two questions. Firstly, for a target type of interest, how long do
we wait until a cell with that type exists? Secondly, what is the probability
that a particular sequence of transitions led to the target type? Our answers
contain simple, explicit formulas that can be used to gain biological insight.
We demonstrate this by considering several applications including the effect of
imperfect drug penetration and the orderings of mutations.
We finish with some concluding remarks, summarising the presented work.
1.3 Mathematical Preliminaries
As discussed above we concern ourself with modelling the development and
initiation of populations. We aim to use a mathematical framework which
captures the key ingredients of the systems under consideration while remaining
analytically tractable. The basis for this framework throughout will be the linear
6
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α 2α (i− 1)α iα (i + 1)α
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Figure 1.1 Population level dynamics of the linear birth-death process with birth
rate α and death rate β, see Section 1.3.1.
α
β
Figure 1.2 Cell level dynamics
of the linear birth-
death process. Cells
replicate with rate α





Figure 1.3 Cell level dynamics




α, die at rate β and
mutate at rate ν, see
Section 1.3.2.
birth-death process for population growth, and Poisson processes for initiation.
Due to their recurrent use throughout this work, we now introduce these objects.
Our intention is to provide a brief, informal outline. Comprehensive rigorous
treatments of these objects may be found in [6, 20].
1.3.1 Stochastic growth: the linear birth-death process
The linear birth-death process (Zt)t≥0 is a one dimensional continuous time
Markov process with the state space of the non-negative integers. It is one of the
simplest examples of a continuous time Markovian branching process [6]. For each
time t, Zt represents the number of cells in a population. Each cell independently
gives birth at a rate α and dies at a rate β. Thus, at the population level the
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transition probabilities satisfy, as τ → 0,
P(Zt+τ = j|Zt = i) =

iατ + o(τ) for j = i+ 1
iβτ + o(τ) for j = i− 1
1− i(α + β)τ + o(τ) for j = i
o(τ) otherwise.
(1.1)
The process at the cell level and population level is illustrated in Figures 1.2 and
1.1.
The marginal distribution starting from a single cell P(Zt = k|Z0 = 1) will be
used repeatedly throughout this thesis. It is most easily found by the backward
Kolmogorov equation, which can be derived using (1.1) and considering the fate
of the initial cell in a small time period. Using the notation P(i)(·) = P(·|Z0 = i),
the backward Kolmogorov equation for the linear birth-death process is
d
dt
P(1)(Zt = k) = αP(2)(Zt = k) + βP(0)(Zt = k)− (α + β)P(1)(Zt = k). (1.2)
The terms on the right hand side of (1.2) correspond to the following events
occurring in a small time period after t = 0: the initial cell replicates, the initial
cell dies, and the initial cell neither replicates nor dies. Note that due to 0 being
an absorbing state for the process, P(0)(Zt = k) = δk,0, where δi,j is the Kronecker
delta function.




t (s) = E(sZt |Z0 = i)
The above definition holds for s ∈ C such that the expectation exists. The key
feature of the generating function used here is that, as the populations initiated










Now, multiplying both sides of (1.2) by sk and summing over all non-negative
integer k, we obtain the corresponding backward Kolmogorov equation in terms











+ β − (α + β)Z(1)t (s). (1.3)
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As (1.3) contains only the generating function when the process is initiated from
a single cell, Z
(1)
t (s), we now fix Z0 = 1 and cease the use of superscripts (i.e.
henceforth P(·) = P(1)(·) etc). Equation (1.3) can be explicitly solved and its
solution, given on page 76 of [7], is
Zt(s) = E(sZt) = 1−
λ/α
1− ξe−λt
, where ξ =
β/α− s
1− s
, λ = α− β. (1.4)
In this thesis λ will be referred to as the growth rate, or fitness of the population.
By expanding the generating function around s = 0, we obtain that the
probability of the population size being k follows a geometric distribution with a
modified zero term












Thus the mode of the distribution is either at 0 or 1, and the mass function
decays geometrically for k > 1. For the particular case of a critical process, i.e.












P(Zt = 0) =
1 for β ≥ αβ/α for α > β. (1.8)
When β = 0 and so the stochastic proliferation follows a pure birth or Yule
process, the cells will be denoted immortal.
From the generating function (1.4) the mean number of cells is obtained as
d
ds
Zt(1) = E[Zt] = eλt.
We can go further and obtain a pathwise description of the growth at large times
by observing that (e−λtZt)t≥0 is a martingale. To show this, note that the number
of cells at time t+ u is comprised of the descendants of all existing cells at time
9





where conditional on Zt, all Z
(i)












Which demonstrates the martingale property. As (e−λtZt)t≥0 is a non-negative
martingale, the martingale convergence theorem [90] (Theorem 11.5) ensures the
existence of a non-negative random variable W such that, with probability one
lim
t→∞
e−λtZt = W. (1.9)
Before offering an interpretation of the above equation let us consider the
distribution of W .
The distribution of W can be deduced as follows. In the case of β ≥ α as
extinction occurs with probability 1, then W = 0 with probability one also. For
α > β, by the continuity theorem [90] (Theorem 18.1), it is enough to consider
the limit of Zt(e
−se−λt) which is the Laplace transform of e−λtZt. From (1.4)
the only time dependent part of Zt(s) is ξe
−λt, whose limit under the mapping













−se−λt) = β/α + (1− β/α) 1
1 + s/(1− β/α)
.
If we let χ be Bernoulli(1− β/α) and W̃ an Exponential(1− β/α) variable, with
χ and W̃ independent of each other, then the right hand side of the above is the
Laplace transform of χW̃ . Hence
P(W ≤ x) = P(χW̃ ≤ x) = β/α + (1− β/α)(1− e−x(1−β/α)). (1.10)
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Therefore the interpretation of (1.9) is that there are two options for the
asymptotic behavior of (Zt)t≥0 pathwise. The process goes extinct with
probability β/α. If extinction is avoided, the population grows as W̃eλt. This
is the meaning of deterministic growth with a random amplitude mentioned
previously.
1.3.2 Stochastic initiation: non-homogeneous Poisson
processes and Cox processes
We shall be interested in the initiation of populations and will use non-
homogeneous Poisson/Cox processes to model the initiation times. Before
introducing these processes, we give a brief motivation by modifying the birth-
death process discussed above. Suppose that in addition to replicating and dying
at rates α, β, cells may also mutate at a rate ν, as is illustrated in Figure 1.3. By
independence, similar to (1.1), in a small time increment τ a mutation event
occurs with probability νZtτ + o(τ). Analogously to the time homogeneous
Poisson process, mutation events accrue with initiation rate νZt. Considering
this process for a fixed realisation of (Zt)t≥0 gives the motivation to introduce the
time-dependent, or non-homogeneous Poisson process.
The initiation times of populations will always be assumed to form a counting
process. A stochastic process (Kt)t≥0 is a counting process if it takes values in
Z≥0, K0 = 0 and it is non-decreasing in t with probability one. Two particular
forms of counting processes will be considered.
Suppose we have a locally integrable non-negative, real valued function, (n(t))t≥0,
where by locally integrable it is meant that for each closed and bounded interval
[a, b] ⊂ R≥0 ∫ b
a
n(t) dt <∞.
The above requirement is motivated by the desire to exclude infinite arrivals over
a finite time interval. For notational simplicity, we will often abuse notation by
referring to n(t) as a function in place of (n(t))t≥0. The counting process (Kt)t≥0
is a non-homogeneous Poisson process with rate n(t) if:
• (Kt)t≥0 has independent increments.
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• For each t, as τ → 0
P(Kt+τ −Kt = k) =

1− n(t)τ + o(τ), k = 0
n(t)τ + o(τ), k = 1
o(τ), k ≥ 2.
Independent increments means that for any disjoint intervals, i.e. [s1, t1] and
[s2, t2] with [s1, t1] ∩ [s2, t2] = ∅, Kt1 −Ks1 and Kt2 −Ks2 are independent. The
function n(t) is called also the intensity of the process. The above implies that




n(s) ds. The quantity m(a, b) =
∫ b
a
n(s) ds is referred to as the mean





Note that the standard homogeneous Poisson process is the special case of
constant n(t). Here we have given the definition with domain R≥0, but this
may be altered to arbitrary subsets of R (or indeed more general spaces).
Returning to our example of a birth death process with mutations, with our
toolkit of non-homogeneous Poisson processes we can now describe the accrual
of mutations for a fixed realisation of (Zt)t≥0. However (Zt)t≥0 is itself a
stochastic process and this motivates extending our discussion to Cox processes.
Cox processes are extensions of non-homogeneous Poisson processes achieved by
letting the intensity itself be random. In particular if (nt)t≥0 is a random real
valued function, locally integrable with probability one, then (Kt)≥0 is a Cox
process if, (Kt)≥0|(nt)t≥0 is a non-homogeneous Poisson process with intensity
(nt)t≥0. Here and throughout this thesis X|Y should be read as X conditioned
on Y .
For our running example, if we let Kt be the number of mutations that have
occurred by t, then the probability of no mutations by t is










In the first equality the tower rule was applied and in the second we used the fact
that Kt|(Zs)s≥0 is Poisson with mean ν
∫ t
0
Zs ds. Equation (1.11) will be critical
in Chapter 3. Other properties of these objects shall be introduced as required.
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Chapter 2
Clone Sizes for Growing Populations
2.1 Introduction and Model
2.1.1 Introduction
Cancerous tumours spawning metastases, bacterial colonies developing antibiotic
resistance or pathogens kick-starting the immune system are examples in
which events in a primary population initiate a distinct, secondary population.
Regardless of the scenario under consideration, the number of individuals in the
secondary population, and how they are clustered into colonies, or clones, is of
paramount importance. An approach which has offered insight has been to bundle
the complexities of the initiation process into a mutation rate and assume that the
primary, or wild-type, population seeding the secondary, or mutant, population is
a random event.
As discussed in the previous chapter, this method was pioneered by microbiologist
Salvador Luria and theoretical physicist Max Delbrück [62]. In their original
model both wild-type and mutant populations grew deterministically, with
mutant initiation events being the sole source of randomness. Lea and Coulson
[60] generalised this process by introducing stochastic mutant growth in the form
of the pure birth process and were able to derive the distribution of the number
of mutants for neutral mutations. This was again extended by Bartlett and later
Kendall [7, 53], who considered both populations developing according to a birth
process. An accessible review discussing these formulations is given by Zheng
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[93].
Recent developments have focused on cancer modelling, where usually mutant
cell death is included in the models. The main quantity of interest in these
studies has been the total number of mutant cells. Explicit and approximate
solutions appeared for deterministic, exponential wild-type growth, corresponding
to a fixed size wild-type population [3, 22, 46, 51, 58], and fully stochastic wild-
type growth either at fixed time or fixed size [5, 27, 54]. An exciting recent
application has been to model emergence of resistance to cancer treatments [12,
14, 55]. The current study continues in this vein with our inspiration being
primary tumours (wild-type) seeding metastases (mutant clones).
Interestingly, in the large-time small-mutation rate limit, the clone size distribu-
tions at a fixed wild-type population size coincide for stochastic and deterministic
exponential wild-type growth [51, 54]. This was recently rigorously proved in [16].
The intuition behind this observation is that a supercritical birth-death branching
process converges to exponential growth in the large time limit, and, for a small
mutation rate, mutant clones are initiated at large times. So asymptotically
the two methods are equivalent, but the deterministic description of the wild-
type population has twofold advantages: (i) the calculations are much simpler in
this case [51], and (ii) the method can be easily generalised to arbitrary growth
functions. This is the programme that we develop in the present chapter.
The present work differs from previous approaches in two ways. Firstly,
motivated by populations with environmental restrictions, we move away from the
assumption of exponential wild-type growth, a setting which, as already noted,
has received limited previous consideration [31]. Explicit solutions are given for
exponential, power-law and logistic growth, which we then extrapolate from to
present general results which are valid for a large class of growth functions. This
extends the classic results found in [6, 50, 52, 81] and recent work in [42, 84]
who considered the wild-type population growth rate to be time-dependent but
coupled with the mutant growth rate. Secondly, rather than the total number
of mutants, our primary interest is on the distribution of mutant number in
the clones initiated by mutation events. This complements [40], which allowed
deterministic wild-type and mutant growth, and the treatment of clone sizes for
constant wild-type populations found in [23]. Whilst we focus on clone sizes, we
demonstrate that the distribution for the total number of mutants follows as a
consequence.
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The outline of this chapter is as follows. Firstly, we define our model and
demonstrate a mapping between the mutant clone size distribution and the
distribution for the total number of mutants. In order to gain some intuition,
this is followed by a short digression on the reduced model when the mutants
grow deterministically also. The exact time-dependent size distribution is given
for exponential, power-law and logistic wild-type growth function in Section 2.2
and some general finite time features are discussed. Section 2.3 pertains to the
asymptotic clone size distribution for general wild type growth and contains
our most significant results. At a fixed clone size, for a large class of wild-
type growth functions, we demonstrate a general two parameter distribution
for clone sizes at large times. The distribution has power-law tail behaviour
which corroborates previous work [27, 46, 91]. Large time results are also given
for the mean and variance of the clone sizes under general wild-type growth.
We follow this with a characterisation of the large clone sizes at long times.
Adopting the interpretation of the wild-type population as the primary tumour
and mutant clones as metastases, we explore our results regarding the tail of
the distribution on an empirical metastatic data in Section 2.5. In our discussion
section, we indicate how some contemporaneous work relates to our results, review
shortcomings of the work and areas for progression, and then give some concluding
remarks.
We remark that some of this chapter has been published in [68], but the work
has been revised, and in places strengthened, for presentation here.
2.1.2 Model
In our model a wild-type population gives rise to mutants during reproduction
events. The arisen mutant also reproduces and so mutant clones stem from the
original initiating mutant’s progeny. We shall be focusing on the case where the
wild-type population’s growth is deterministic for two reasons. Firstly, in many
application the wild-type population is significantly larger than the mutant clones.
Secondly, if we wished to consider clone sizes under stochastic wild type growth
then an appropriate first step would be to obtain results conditioned on the
wild type growth, which is equivalent to the setting studied in this chapter. For
logistic wild-type growth a sample realisation of the process is shown in Figure
2.1. Further details of the model are now given.
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Figure 2.1 A sample realisation for deterministic logistic wild-type growth, with
a carrying capacity of 50, and stochastic mutant growth. Note that
we are typically motivated by the case when the wild-type population
is much larger than individual clones.
Mutant clone size distribution
Stochastic growth of mutants will follow a birth-death branching process [6], as
discussed in 1.3. We follow the notation introduced there, in particular letting Zt
be the number of cells at time t in a birth-death process initiated with a single
cell, and Zt its generating function. In this chapter, we shall scale time such
that each mutant has unit birth rate and death rate β. If we let the timescale
in Section 1.3 be t′, with birth and death rates α′, β′, this is accomplished by
defining the timescale in this chapter as t = α′t′. This in turn implies that all




. This will simplify the presentation.
We will be interested in statistics of the system at a fixed observation time t.
The manner of growth of the wild type until t is critical and to discuss this we
let the number of wild-type individuals be denoted by nτ for 0 ≤ τ ≤ t. Since
we suppose mutants are produced by wild-type individuals, the rate of mutant
clone initiations will be proportional to the product of nτ and the mutation rate
ν. More precisely, the process of clone initiations is a non-homogeneous Poisson
process with intensity νnτ as in 1.3.2. Let the Poisson random variable Kt denote





Note due to the local integrability property of nτ given in Section 1.3.2, for any
t, Kt <∞ with probability one.
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We comment that, if one adopts the interpretation of using deterministic wild-
type growth as an approximation to an underlying stochastic process, then many
different processes may map to the same deterministic nτ . To illustrate this
point, let us suppose that the wild-type population truly follows the linear birth-
death process with mutation of Section 1.3 with birth, death and mutation rates
αw, βw and ν. We approximate the number of wild type cells as nτ = e
δτ with
δ = αw − βw. It is clear that for any c, altering the birth and death rates to
αw+c, βw+c will lead to the same deterministic approximation nτ . Reassuringly,
the expected number of clones by a given time, (2.1), will also be unchanged under
these altered death rates (equation 7 in [5]). However, if we instead defined the
linear birth-death with mutations as: replications appear at a rate αw, and one
of the daughter cells is a mutant with probability µ, then altering the birth rate
αw would change the number of clones initiated by a given time, even if the mean
number of wild-type cells is the same. Thus care must be taken when using a
deterministic approximation to the number of wild-type cells when a particular
underlying stochastic process captures the true wild-type dynamics.
At time t > 0, assuming Kt > 0, by the order statistics property for Poisson
processes ([50] Chapter 13) the unordered clone initiation times before t, (T (i))Kti=1
















Note at is the expected number of clones seeded when the mutation rate is unity.
To each initiation time T (i) we associate an iid linear birth-death process (Z
(i)
s )s≥0.










where the first member of the unordered clone sizes has been chosen arbitrarily
(thus Yt is equal in distribution to any of the Z
(i)
t−T (i) due to their iid nature).
We henceforth drop the superscripts as the linear birth-death processes (Z
(i)
s )s≥0
are all iid. As we identified each of the Kt initiated clones by their associated
unordered arrival times, and as each of the T (i) is equal in distribution to a
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uniformly chosen sample from the ordered clone arrival times (Ti)
Kt
i=1, Yt may
have been equivalently defined as the size of a mutant clone uniformly sampled
from the Kt initiated clones.
By conditioning on the initiation time of Yt, we see that





nτP(Zt−τ = k) dτ. (2.3)
In turn the generating function of the clone size is given by





nτZt−τ (s) dτ, (2.4)
where the expectation and integral may be interchanged as all terms are non-
negative.
We make the following remarks on the above: (i) The mutation rate ν does not
appear in the density for initiation times in (2.2), hence mutant clone sizes are
independent of the mutation rate and thus all following results regarding clone
sizes will be also. (ii) The integral in (2.3) is a convolution and as convolutions
commute we may swap the arguments of the integrand functions (nτZt−τ ↔
nt−τZτ ). (iii) If we start with n0 wild-type individuals, so the wild-type follows
mτ = n0nτ , then both the numerator and denominator in (2.2) will have a factor
of n0, which cancel. So henceforth, apart from when n0 = 0 (used occasionally
for analytic convenience), we set n0 = 1 without loss of generality. (iv) By
similar logic, a positive random amplitude for the wild-type growth function, i.e.
mτ = Xnτ for a general positive random variable X, would also cancel and so our
results on clone sizes hold in that case also. Note this includes the asymptotic
behaviour of a birth-death process as discussed in Section 1.3.1. (v) If only clones
above a certain size are of interest, say clones larger than k∗ cells, then as
P(Yt > k|Yt ≥ k∗) =
P(Yt > k)
P(Yt ≥ k∗)
, k ≥ k∗
we see that only the amplitude of the mass function is altered in this case. This
comment is particularly relevant to Section 2.5, where we consider metastases,
which are typically only observable when greater than 107 cells [14]. However the
analysis of Section 2.5 will focus on the shape of the mass function, and so the
altered amplitude of the conditioned clone size distribution will not be important.
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2.1.3 Mapping distributions: clone size to total mutant
number
This section is related to the classic Luria-Delbrück problem. Let Bt be the total





where all (Yt)i are iid random variables specifying the clone sizes. As such, Bt is
a compound Poisson random variable, and hence its generating function is
Bt(s) = E(sBt) = eE(Kt)[Yt(s)−1], (2.5)
which can be derived by conditioning on Kt. It follows that
E(Bt) = E(Kt)E(Yt) and Var(Bt) = E(Kt)E(Y 2t ). (2.6)
Notice that the ratio of the variance to the mean is dependent only on the clone
size distribution, and thus we will recover the result of Delbrück discussed at the
beginning of Chapter 1 for the case of exponential wild type growth. The link
between the mass functions of the mutant clone size, Yt, and the total number of
mutants, Bt, is given by
P(Bt = n) =
eE(Kt)(P(Yt=0)−1) n = 0E(Kt)∑n−1k=0 n−kn P(Bt = k)P(Yt = n− k) n ≥ 1.
This is a consequence of the following lemma, which is stated without proof in
[93] (Lemma 2). For lack of a reference we provide a proof.
Lemma 2.1.1. Consider generating functions F (s) =
∑
n≥0 pns
n and G(s) =∑
n≥0 qns
n where F (s) = eG(s). Then p0 = e






Proof. Clearly p0 = e
q0 from F (0) = eG(0). By differentiating F (s) we obtain











which can be shown by induction using Pascal’s formula for binomial coefficients.
Evaluating the above equation at s = 0 and using that F (m)(0) = m!pn and
G(m)(0) = m!qn we arrive at the announced recursion.
Hence while we may initially work in the setting of size distribution of a single
clone, by the above discussion, results are transferable to the total number of
mutants case.
Often long-time results are sought, which significantly reduces the complexity of
the distributions. For any fixed positive mutation rate, in the long-time limit,
an infinite number of clones will have been initiated, resulting in limt→∞ P(Bt <
∞) < 1. A common solution to this problem is the Large-Population Small-
Mutation limit [51]. The interpretation of this limit is that we are interested in
the number of mutants at a large observation time t, and the mutation rate for
the process (which unfolds over the time interval [0, t]) is chosen to be ν = θ/nt.
Then for exponential wild-type growth (or exponential-type, see Section 2.3.1)












demonstrating that the limit of the clone size distribution is of primary concern.
Furthermore, if the expected number of initiated clones is small, we have the
following proposition.
Proposition 2.1. For a small expected number of initiated clones, conditioned
on survival, the size of a single clone and the total number of mutants are
approximately equal in distribution. That is,
P(Bt = k|Bt > 0) = P(Yt = k|Yt > 0) +O(E(Kt)), as E(Kt)→ 0.
Proof of Proposition 2.1. using generating functions and the relevant Taylor
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expansions,













+O(E(Kt)) = E(sYt |Yt > 0) +O(E(Kt)).
One immediate consequence of this result is that for immortal mutants (β = 0)
and E(Kt) 1 we have
Bt(s) ≈ (1− e−E(Kt))Yt(s) + e−E(Kt) =⇒ P(Bt = k) ≈ E(Kt)P(Yt = k) for k ≥ 1.
This agrees with intuition as for small enough E(Kt), we expect only 0 or 1 clones
to be initiated and hence the total number of mutants will be dictated by the
clone size distribution. With exponential wild-type growth this approximation
was used in [46] to investigate drug resistance in cancer.
2.1.4 A first approximation: deterministic mutant growth
Before discussing some exact results for the above model, we take a short
digression to discuss the simpler model where the size of each mutant clone grows
deterministically. That is we consider the same process as defined above but the
size of a mutant clone, at a time s after initiation will follow
Z ′s = e
λs.
The equivalent random variables to those introduced thus far will be given a
prime to indicate we work with a reduced model. Many of the characteristics
of the more complex model are present in this setting. The simple calculations
presented here should facilitate understanding of the later discussion.
In this setting the size of a randomly sampled clone, Y ′t , for 1 ≤ y ≤ eλt is
P(Y ′t > y) = P(eλ(t−T







For the particular case of exponential wild type growth, that is nτ = e
δτ with
δ > 0, this yields






Of note is that, for large times, the clone size density will be a power law decaying
as y−δ/λ−1. We contrast this with the case of a constant wild type population
nτ = 1, which results in
P(Y ′t > y) = 1 +
log(y−1)
λt
Thus the density for clone sizes will decay as (yλt)−1 in this case.
We make two observations. We firstly note that the power-law densities derived
are a consequence of ‘early arriving clones’, by which we mean clones initiated
close to the beginning of the process. In the exponential case these early arrivals
are rare but when they occur, they are likely to be large. Using (2.6), we see this
will result in a high variance for the total number of mutants. This observation
was the means by which Luria and Delbrück were able to distinguish spontaneous
from adaptive mutations [62]. Furthermore by examining the density of initiations
(2.2) in each case, early arriving clones are more likely for constant wild type
growth than exponential. This explains the ‘heavier tail’ in the constant setting.
2.2 Finite time clone size distributions
We now return to our original model where each mutant clone grows according to
a linear birth-death process and examine some particular cases where the clone
size distribution may be computed exactly. This will allow us to see how the
distribution is altered for different wild type growth but is also motivated by
the fact that in the exponential growth case, for the total number of mutants,
the full distribution can be obtained with discrete mutant growth but remains
elusive when the reduced model used in the previous section (deterministic mutant
growth) is employed [93]. Additionally, these results will hold regardless of the
sign of λ (later we will focus on λ > 0).
Three particular cases of wild-type growth function, nτ , will be considered
namely: exponential, power-law and logistic. Exponential and logistic growth
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are widely used in biological modelling [66]. For the power-law cases, under the
assumption that the radius of a spherical wild-type population is proportional
to time, quadratic and cubic power-law growth represents mutation rates
proportional to the surface area and volume respectively. In each case an
‘explicit’ representation is given for the generating function. These are displayed
in Table 2.1. As the derivation of these generating functions mostly consists of
manipulating special functions, we relegate the derivation to Appendix A.2.
Wild type growth function Clone size generating function
Exponential nτ = e


















with γ = δ/λ
Power law nτ = τ






















Table 2.1 The clone size generating function for special cases of the wild







function, Lii(s) is the polylogarithm of order i, and ξ is defined in
(1.4)
The associated probability mass functions for the generating functions given in
Table 2.1 are shown in Figure 2.2 at short, medium and long times. Of note
is that for short times all mass functions have an exponential cut-off, for the
chosen parameters, occurred for clone sizes approximately 20. Also at large
times the exponential case has distinct behaviour from all other growth functions.
While exact expressions for the mass functions are given in Appendix A.2, the
numerical values displayed in Figure 2.2 were obtained via Cauchy’s integral
formula, which may be efficiently computed using the fast Fourier transform. For
a brief discussion on implementation see [4] and references therein.
The mass functions are particularly simple in the following two cases, which we
highlight so as to compare with the discussion of Section 2.1.4. For exponential
wild type growth (nτ = e
δτ ) and immortal, neutral mutants (δ = λ, β = 0) we
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Figure 2.2 Clone size distribution for different wild type growth for short,
medium and long times obtained using the generating functions given
in Table 2.1. Parameters constant across plots: δ = 1.8, λ = 1, K =
20000. Times used: t = 3, t = 9, t = 15.
have






or P(Yt > k) =
φk
k + 1
with φ = 1− e−δt.
While for a constant wild type population (nτ = n0)
P(Yt = k) =
1 + t−1 log(1− S−1t ) k = 01
tk
S−kt k ≥ 1.
(2.7)
where as in (1.6) St =
1−e−λtβ
1−e−λt (when comparing recall α = 1 in this chapter).
Monotone distribution and finite time cut-off
We conclude this section by demonstrating general features that exist in the clone
size distribution at finite times, namely a monotone decreasing mass function and
an exponential cut-off. These features can be seen Figure 2.2 at ‘short times’.
Note that the mass function for the birth-death process is monotone decaying
and the following short proposition is a consequence of this.
Proposition 2.2. As long as nτ is positive for some subinterval of [0, t], then
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for k ≥ 1 we have P(Yt = k + 1) < P(Yt = k) for any finite t > 0.
Proof of Proposition 2.2. Using (2.3), we see that for k ≥ 1





nt−τ [P(Zτ = k + 1)− P(Zτ = k)] dτ.
Now from (1.5) it is clear that the integrand is negative for finite, positive τ giving
the result.
Whether P(Yt = 0) ≥ P(Yt = 1) depends on nτ and t. Note that in contrast, the
mass function of the total number of mutants is not monotone in general [51].
Now as an example consider the mass function when the size of the wild-type
population is constant, which is given by (2.7), and specifically for k ≥ 1 and
λ > 0. For any moderate t, S−1t is typically close to (but strictly less than) one
but for large k, S−kt will become the dominant term in the mass function, dictating
exponential decay. We term this a cut-off in the distribution. To determine where
the cut-off occurs, note, with 1 > ε > 0, we can write S−kt = (1 − ε)k which
is approximately 1 for εk  1. However this approximation breaks down for
k ≈ ε−1. Therefore we can deduce the cut-off occurs at approximately k ≈ eλt/λ.
It is an artifact of the mass function for the birth-death process (1.5). Hence we
will have (at least) two behaviour regimes for the mass function for finite times.
Here we show that this cut-off exists generally for finite times.
Theorem 2.1. Let nτ be continuous and positive for τ ∈ [0, t]. Then
P(Yt = k) = S−kt Θt(k),




and St is given by (1.6).
We interpret the fact that lim supk→∞
k
√
Θt(k) = 1, as; regardless of the precise
form of Θt(k), for large k it neither grows nor decays at a geometric rate or faster.
The proof is an application of Theorem IV.7 in [30], which we now state using
the notation that for any analytic function f(z) =
∑
n≥0 fnz
n, the nth coefficient
is denoted as [zn]f(z) = fn.
Theorem 2.2 ([30]: Exponential Growth Formula). If f(z) is analytic at 0 and
R is the modulus of singularity nearest the origin in the sense that R := sup{r ≥
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which is claimed to be at St. Indeed, we note that for |s| < St, Zτ (s) is analytic
for all τ and as nτ is continuous we can conclude that the It(s) is analytic in this






∣∣∣∣ = ε∣∣∣∣βt+ log [ λ1− βe−λt − s(1− e−λt)
]∣∣∣∣.
The rightmost expression can be seen to have closest to origin singularity at St
and as atYt(s) = It(s), by Theorem 2.2, we can conclude Theorem 2.1.
When λ > 0, St > 1 for finite t, and St → 1 exponentially fast for large t. Hence
the cut-off will disappear for long times and the subexponential factor, discussed
in detail in Section 2.3, will completely determine the tail of the distribution.
Also notice that the power-law cases, nτ = τ
ρ, for ρ ≥ 1 are not covered as,
to make the analysis tractable, they artificially start at n0 = 0. However the
generating function in this case, giving in Table 2.1, also has its closest to origin
singularity at St so the cut-off exists there also.
2.3 Large time features: results
In this section we give results regarding the large time behaviour of our model. In
many applications the cut-off location (k ≈ eλt/λ) is so large that the distribution
at or above this point is of little relevance and hence for this purpose the limiting
approximations now discussed are of particular interest. Using the notation of
Theorem 2.1, this section investigates the large time form of Θt(k). In particular
we can explain the collapse of the mass functions for non-exponential wild type
growth at long times seen in Figure 2.2. We highlight the power-law decaying,
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‘fat’ tail found in each case, echoing the analysis of Section 2.1.4. Henceforth we
assume λ > 0, i.e. a supercritical birth-death process.
The analysis will be split in two parts. The first concerns the asymptotic
distribution of P(Yt = k) at a fixed k, while in the second we examine P(Yt = k)
for k of order eλt. The techniques used for each section are disjoint, and so that
we can present a coherent narrative we delay the proofs for this section until
Section 2.4.
2.3.1 Fixed clone size
In this section we consider the long time limit for the clone size distribution at a
fixed size. We are able to characterise the limit of P(Yt = k) for a large class of
wild type growth functions, which we now introduce.
General wild type growth functions
To give general results we introduce the following assumption which will be
assumed to hold for the remainder of this section.
Assumption 1. For wild-type growth function nτ we assume
(i) nτ is positive for all τ > 0 and nτ = 0 for τ < 0.
(ii) nτ is right continuous with left limits (cadlag).
(iii) For x ≥ 0 the limit limτ→∞ nτ−x/nτ exists, is positive and less than or equal
to 1.
We note that the cases discussed in Section 2.2 are all covered by Assumption
1. The reason for the seemingly arbitrary limit assumed in (iii) becomes clear
with the following result which is an application of the theory of regular variation
found in [10].











= δ∗ ≥ 0.
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Often the long-time behaviour of the clone size distribution may be separated
into δ∗ > 0 and δ∗ = 0, and so we give the following definition [30].






holds for some δ∗ ∈ R. Then f(x) is of exponential-type for δ∗ 6= 0 and is
subexponential for δ∗ = 0.
Simple examples of subexponential functions are e
√
t, log(t), tρ, while eδt, eδttρ
are of exponential-type, with δ, ρ ∈ R.
Mean and variance
We now address the asymptotic properties of the clone size distribution by first
discussing its mean and variance.


































The leading asymptotic behaviour which has different regimes dependent on δ∗/λ
is illustrated in Figure 2.3. As an example, for the exponential case nτ = e
δτ ,
by using (2.6) and the results found in [51], then δ∗ = δ, s1(t) = λt, s2(t) =
δ
λ−δ , s3(t) = 4t and s4(t) =
2δ
λ(2λ−δ) . If we let δ = λ and stop the process when
the wild type reaches N = eδt, then Var(Yt)/E(Yt) ∼ 2N/(δ logN), recovering
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Figure 2.3 Illustration of the asymptotic behaviour of the mean and variance as
given in Theorem 2.3.
Large time clone size distribution
Turning to the distribution, we have the following result regarding the generating
function at large times.





















This result is made clearer in the next corollary, in which the cases of exponential-







For a proof see Lemma 2.4.1. Consequently in the exponential-type setting, the
limiting result is a proper probability distribution, whilst in the subexponential
case it is not. We can interpret this as the clone sizes staying finite in the
exponential case but grow to infinity for subexponential cases at large times.
Unpacking Theorem 2.4 yields the following.
Corollary 2.1. For |s| < 1,
lim
t→∞













(Yt(s)− β) = log(1− ξ) γ∗ = 0,
Then for t→∞ the probabilities for exponential-type growth γ∗ > 0 are








































Figure 2.4 Transition to the asymptotic regime as described in Corollary 2.1.
For subexponential wild-type growth the mass functions tend to k−1
behaviour, while for exponential-type it tends to k−1−γ
∗
. Same as
‘long time’ in Figure 2.2.
and for subexponential growth (γ∗ = 0)








The expressions obtained in the δ∗ > 0 case also appeared as an approximation
in [54] for the total number of mutants with stochastic wild-type and mutant
growth when the mean number of clones is small. The agreement between the
total number of mutants and the clone size distribution is to be expected by
Proposition 2.1. That the above gives the clone size distribution when the wild
type also grows as a birth-death process will be discussed shortly.
The case of immortal mutants does not simplify the above expressions for
subexponential growth, but for exponential-type growth, by applying (A.2) then
(A.1) to the limiting generating function, we have the following link to the Yule-
Simon distribution which appears often in random networks [59, 76].
Corollary 2.2. For immortal mutants with exponential-type wild-type growth the
clone size distribution Yt follows a Yule-Simon distribution with parameter δ
∗ for














and thus, for k ≥ 1,
lim
t→∞




With immortal, neutral (δ∗ = 1) mutants we have
lim
t→∞




which is in agreement with the long time limit of (2.2). As a point of interest,
note in the immortal, neutral case the mode of the limiting distribution is at
k = 1, but the expected value is infinite.
For immortal mutants and exponential-type growth, as the clone size distribution
tends to a Yule-Simon distribution, we expect power-law tail behaviour at large
times [67]. Interestingly, we see that this behaviour holds when we include mutant
death and have general wild-type growth.
Corollary 2.3. At large times, the tail of the clone size distribution follows a












Observe that the exponent in the power-law tail for the constant and exponential
growth is the same as that obtained with the deterministic approximation in
Section 2.1.4. Further note the ordering of the limits cannot be interchanged as
for fixed t, due to the cut off shown in Theorem 2.1, limk→∞ k
1+γ∗P(Yt = k) = 0.
An implication: clone sizes in the fully stochastic Luria-Delbrück model
We briefly highlight an implication of the results of Section 2.3.1 when the wild
type growth function is a stochastic process. In particular, consider the scenario
when clones are initiated as a Cox process with intensity (νAs)s∈R , where (As)s≥0
is a linear birth-death process with growth rate δ, and As = 0 for s < 0. This
is the setting where the clone initiation times are generated by the birth-death
mutation process of Section 1.3.2. The birth-death processes dictating clone
growth are independent of (As)s≥0. This corresponds to the clone sizes in the
fully stochastic Luria-Delbrück, or two type branching process, model [5, 54].
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Fix a realisation of the the process, ω, such that At(ω) > 0 for all t, that is the
wild type does not go extinct. Then we see that (At(ω))t∈R satisfies the first two
conditions of Assumption 1. For the third, by the martingale convergence given












Therefore, for each ω such that the wild type does not go extinct the asymptotic
clone size distribution is given by Theorem 2.4. Hence the asymptotic clone size
distribution in the fully stochastic Luria-Delbrück model, conditioned that the
wild type does not go extinct is given by Theorem 2.4. This was also shown in
[16], as a consequence of a general result on the convergence of mutation times,
but still using the martingale convergence of (1.9).
2.3.2 Large clone size
Thus far we have seen an exponential cut-off exists around k ≈ eλt/λ and for
a fixed k we can describe the clone size distribution, P(Yt = k), at large times.
For some applications, in particular cancer where the observable metastases (the
clones) are of sizes larger than 106 cells, it is the large clones we are interested
in. It is unclear whether the results of the previous section sufficiently describe
the distribution of large clones. We have not been able to answer this question
fully, but in this section we show some progress in characterising the clones of
size around the cut-off. For consistency we again assume Assumption 1.
We follow [81] to describe the size distribution for large clones at long times via
a Poisson process. The idea is to obtain a description of the time-ordered clones.
To this end let (Ti)i≥1 ⊂ (0,∞) be the clone initiation times taken from points
of a Poisson process with intensity νnτ , for τ ≥ 0. Further let Ỹi(t) be the size
of the ith initiated clone at time t, where if t < Ti, Ỹi(t) = 0. To connect to the
variables discussed thus far Kt = |{Ti}i≥1 ∩ [0, t]| and Yt is uniformly sampled
from {Ỹi(t)}Kti=1.
Then the following theorem gives a Poisson process description of the clone sizes.






where each Wi is iid, with distribution given by (1.10). Furthermore, defining
K̃(u) = |{e−λTiWi}i≥1 ∩ (0, u)|







ds <∞, x > 0. (2.8)
For the Poisson process of Theorem 2.5, as for ε > 0, m(ε,∞) <∞ we have that
the number of e−λTiWi > ε is finite almost surely. Thus we may sample uniformly
from this set (i.e. {e−λTiWi}i≥1 ∩ (ε,∞)) and construct a random variable Y (ε)
with distribution
P(Y (ε) > x) =
m(x,∞)
m(ε,∞)
, x ≥ ε.
The new variable Y (ε) can be related to the previously considered random variable
Yt by the following result.
Theorem 2.6. For ε > 0, with Y (ε) as above,
lim
t→∞
P(Yte−λt > x|Yte−λt > ε) = P(Y (ε) > x), x ≥ ε.
Theorem 2.6 only concerns the asymptotic distribution of clones larger than
εeλt and so pertains to large clones. Of note is the reappearance of power-law
behaviour with a cut-off in the density of Y (ε). For example in the constant




P(Y (ε) ≤ x) = e
−λx
xΓ(0, λε)
, x ≥ ε.





(1 + λx)εeλε, x ≥ ε.
Note that the exponents in the power-law terms is equal to that given in Corollary
2.3, indicating the two approaches are complimentary. However we have not been
able to characterise this distribution in a general fashion as in Theorem 2.4.
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2.4 Large time features: proofs
Here we present proofs for the asymptotic results given in the previous section.
2.4.1 Fixed clone size
Our aim is to characterise the long time behaviour of P(Yt = k) for a class of wild
type growth functions. It will be seen that that Assumption 1 (iii) allows us to use
the theory of regularly varying functions. The study of such functions is a sub-
branch of real analysis but they may typically be encountered as assumptions
on the manner in which the tail of a cumulative distribution function decays.
The reason for this is that these functions can be thought of as ‘asymptotically
behaving as a power-law’, and power-law decay of a tail gives information on
which moments exist of a distribution. However in our setting, in Figure 2.2
we saw that exponential type growth gave a distinctive clone size distribution
relative to the other growth functions. By a variable change we can adapt the
theory of regular variation for our purposes.
We start by collecting some definitions and required properties from [10]
Definition 2.2. [10] A Lebesgue measurable function f : R+ 7→ R that is





= xκ, x > 0.
The notation f ∈ RVκ will be used and we will denote f ∈ RV0 as slowly varying
functions.
Theorem 2.4.1 ([10]: Characterisation Theorem). Suppose f : R+ 7→ R is
measurable, eventually positive, and limt→∞
f(tx)
f(t)
exists, and is finite and positive
for all x in a set of positive Lebesgue measure. Then, for some κ ∈ R,
(i) f ∈ RVκ.
(ii) f(y) = yκl(y) where l ∈ RV0.
Proposition 2.4.1 ([10]: Proposition 1.3.6). For f ∈ RVκ limt→∞ log f(t)log t = κ.
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Theorem 2.4.2 ([10]: Karamata’s Theorem). If f ∈ RVκ, X sufficiently large
such that f(y) is locally bounded in [X,∞), and κ > −1, then∫ y
X
f(s) ds ∼ yf(y)
κ+ 1
as y →∞.
Proposition 2.4.2 ([10]: Proposition 1.5.9.a). Let l ∈ RV0 and choose X so that














Note cadlag functions satisfy the local boundedness and local integrability
properties, as they are bounded over compact intervals [9] (chapter 3). We now
turn to the proofs.
Proof of Lemma 2.1. Choose x ≥ 0 and let y = et, c = e−x. Consider the























= δ∗ ≥ 0.
The non-negativity of δ∗ follows from Assumption 1 (iii).
To prove Theorem 2.3 we require the following:
Lemma 2.4.1. There exists subexponential functions s1(t), s2(t) such that
(i) nt = e
tδ∗s1(t).












C δ∗ < η
as t→∞.
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We highlight that neither subexponential function depends on η.
Proof. (i) For y = et, nlog y = g(y). Now g ∈ RVδ∗ hence g(y) = yδ
∗
l(y) with
l ∈ RV0 by Theorem 2.4.1(ii). Setting s1(log y) = l(y), by Lemma 2.1, s1(t) is
subexponential. (ii) Let g(y) be as above. With δ∗ > η ≥ 0 and using the change














where the asymptotic equivalence is due to Theorem 2.4.2 applied to g(y)y−1−η ∈
RVδ∗−η−1 and the final equality is by part (i). For δ
∗ = η, by Theorem 2.4.1(ii)
the integrand will be a subexponential function. Applying the same change of
variables as in (2.9) we see by Proposition 2.4.2(i) that the integral is a slowly
varying function in y and hence is subexponential in t, which we denote s2(t). Now




which by a basic result for Laplace transforms, see, e.g., Theorem 1.11 in [75],
ensures convergence to a finite, positive constant.
As an example, which will be useful for the next proof, we apply the above lemma













Proof of Theorem 2.3. We require the first and second moments of Zt which may




































Throughout let st be a generic subexponential function and it will be helpful to
observe that the reciprocal or constant multiples of a subexponential function
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are subexponential. We first consider the mean. For the cases δ∗ 6= λ, applying
Lemma 2.4.1(ii) to (2.10) with η = λ for the numerator and η = 0 for the



















That s1(t) diverges can be seen by applying the standard change of variables
t = log(y), τ = log(s) coupled with Proposition 2.4.2(ii). Turning to the variance,
with Var(Yt) = E(Y 2t )−E(Yt)2, when δ∗ > 2λ we apply Lemma 2.4.1(ii) term by













The last relation is due to the monotonicity of at, a consequence of Assumption
1 (i). The desired representation is obtained by applying Lemma 2.4.1(ii) to at
and absorbing C1 into s4(t). When λ ≤ δ∗ < 2λ the same argument holds as long














By Proposition 2.4.2(i) the rightmost integral is a subexponential function and
as we may always choose t sufficiently large such that s
1/t
t < e





−λt dτ → 0.




−λt dτ demonstrates the contribution from
the mean squared is negligible. For δ∗ = 2λ we apply the same argument as in
(2.12) to each term and this completes the proof.
In order to prove Theorem 2.4 we require the following lemma.
Lemma 2.4.2. For |s| < 1, β ∈ [0, 1), u ∈ [0, 1] and ξ as in (1.4), we have∣∣∣∣ ξ1− ξu
∣∣∣∣ ≤ ∣∣∣∣ β − s1−max{β, |s|}
∣∣∣∣ .





1− s− (β − s)u
.
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The triangle inequality yields
|1− s− βu+ su| = |1− (βu+ s(1− u))| ≥ |1− |βu+ s(1− u)||
and
|βu+ s(1− u)| ≤ uβ + (1− u)|s| ≤ max{β, |s|}.
The claimed inequality now follows.
Proof of Theorem 2.4. Taking the generating function for Yt from equation (2.4)
we apply the change of variables u = e−λτ which gives





























δ∗/λ. Hence there exists t∗, such that




∗/λ + 1. For t ≤ t∗ the above is bounded, as
cadlag functions are over finite intervals. Coupling this with Lemma 2.4.2 shows
the integrand may be dominated. By assumption the integrand converges and



























The final equality follows from applying (A.4) then (A.2).
Proof of Corollary 2.1. The first statement is given by applying Lemma 2.4.1(ii)
to at/nt. Then taking the limiting generating function in Theorem 2.4 we firstly
apply (A.2) then (A.3) which yields generating function representation for γ∗ = 0.
The mass function for γ∗ = 0 is simply a logarithmic expansion. For γ∗ > 0 we
use the expression given in Appendix A of [51] to obtain a series expansion for
the generating function in terms of s and the coefficients of the expansion give
the mass function.
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Proof of Corollary 2.3. The analysis involves expanding the limiting generating
function in Theorem 2.4 around its singularity at s = 1 and exactly mirrors that
given in section 6 of [51] and so is omitted.
2.4.2 Large clone size
We start by proving the Poisson description of clone sizes.
Proof of Theorem 2.5. The proof of the first statement follows Theorem 3 in [81].
The general idea can be seen by considering the limit of the first clone. Let Z(1)(t)
be a linear birth-death process, independent from the Poisson process (Kt)t≥0.
We have that Ỹ1(t) = Z
(1)(t−T1)I{t≥T1}. By the martingale limit in Section 1.3.1,
in particular equation (1.9), we have,
e−λtZ(1)(t− T1) = e−λT1e−λ(t−T1)Z(1)(t− T1)→ e−λT1W1 a.s.
Similar statements hold for each e−λtỸi(t), which implies convergence of the
sequence.
We now turn to the Poisson description, which is similar to the proof of Theorem
4 in [81]. We’ll aim to show K̃(a, b) = K̃(b)− K̃(a) is Poisson with mean m(a, b).
First though let us take A,B to be open subsets of R>0 and consider Ñ(A×B) =
|{(Ti,Wi) ∈ A×B}|, that is the number of points that fall in the (open) rectangle
A×B. We already know that the number of Ti falling in A is Poisson with mean∫
A
νnτ dτ , thus for Ñ(A×B) we simply do not count those Ti, whose associated
Wi does not fall in B. This is a thinning of our original Poisson process (Kt)t ≥ 0




Therefore, for any open S ⊂ R2>0 (which can be decomposed into open rectangles),







The reason for the ‘extra’ λ (as opposed to just the exponential density) is due
to P(Wi > 0) = λ. Arguing similarly (using the independent increments on the
Ti) for sets S1, S2, Ñ(S1), Ñ(S2) are independent Poisson variables.
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Turning to K̃(u), we observe that
K̃(a, b) = Ñ
(
{(τ, w) : a < e−λτw < b}
)
.
This implies K̃(a, b) is Poisson with mean











−λaeλτ − e−λbeλτ ) dτ.
Independent increments follows as a consequence of the independent sets property
for Ñ . The given representation of m(x,∞) is achieved by a change of variables.
That m(x,∞) <∞ is due to the above integrals being convergent, as by Lemma




Proof of Theorem 2.6. Immediately from (2.3) we see






nt−τP(Zτ > xeλt) dτ∫ t
0
nt−τP(Zτ > εeλt) dτ
.
It is enough to examine the numerator. As, from (1.5),
P(Zt > k) = (1− βS−1t )S−kt , k ≥ 0
we have∫ t
0











Here bac denotes the integer part of a, and is necessary as P(Zt > k) is defined
on the non-negative integers. Focusing on the first term from the right hand side




−bxeλtc(log(1− βe−λτ )− log(1− e−λτ ))
)
dτ.




eλ(1−s) which is integrable over [x,∞) by m(x,∞) <

















The second integral from the right hand side of (2.13) can be treated analogously












and the claimed result follows.
2.5 An application: tail behaviour in empirical
metastatic data
Given the discussion thus far we expect, for a large class of wild-type growth
functions, to see power-law tail behaviour on approach to the exponential cut-off
in the clone size distribution. We take the first steps to verify this theoretical
hypothesis by analysing an empirical metastatic data. In this setting the wild-
type population is the primary tumour, mutant clones are the metastases and
the mutation rate is the rate at which metastases are seeded from the primary.
Our aim here is to explore whether adapting our model to this setting is at all
reasonable (rejection of a power law tail in the metastasis sizes would imply it is
not).
The data is sourced from the supplementary materials in [14]. This data is taken
from 22 patients; 7 with pancreatic ductal adenocarcinomas, 11 with colorectal
carcinomas, and 6 with melanomas. One patient had only a single metastasis so
we discard this data. Of the 21 remaining patients the number of cells in a single
metastasis ranged from 6 × 107 to 2.23 × 109. Our theoretical model predicts a
cut-off in the distribution around k = eλt/λ. Taking some sample parameters
from the literature, namely λ = 0.069/day [24], and t = 14.1 years [92], this leads
to a cut-off around k ≈ 10154 cells. Due to the enormity of this value we ignore
the cut-off here. Additionally, as the minimum observed metastasis size is 6×106
cells, we assume that all data points are sampled from the tail of the distribution.
2.5.1 Likelihood methodology
We broadly follow the methodology outlined in [17]. For each of the datasets, one
from each patient, we examine the likelihood ratio to determine if the data is more
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likely sampled from a power-law decaying or geometrically decaying distribution.
In particular for each metastasis dataset y = (y1, . . . , yN) we wish to test the
hypothesis that the elements of y are drawn iid from P1(Yt = y;ψ) = C1y−ψ for
y ≥ k∗, versus that that they are sampled from P2(Yt = y; p) = C2p(1 − p)y for
y ≥ k∗. Here C1, C2 are normalising constants and k∗ is chosen as the ‘beginning




[logP1(Yt = yi; ψ̂)− logP2(Yt = yi; p̂)],
where ψ̂ is the maximum likelihood estimate (MLE) for ψ assuming the data is
drawn from P1(Yt = k;ψ) and p̂ is the MLE assuming P2(Yt = k; p). We see that
R̂ > 0 gives support to the hypothesis that the data is drawn from the power-law
decaying distribution relative to a distribution with a geometric tail.
Given a set of metastases sizes, y, to calculate R̂ it remains to obtain the MLEs.
We derive the MLE in detail for geometric tail decay, the power-law case is
analogous but for the final step. Here y is assumed to be a realisation of the
random vector Yt = (Y
(1)
t , . . . , Y
(N)
t ). All Y
(i)
t are iid with distribution P2(Yt =
y; p) = C2p(1 − p)y. Let A = P2(Yt < k∗; p) (the weight of the distribution
contained before the beginning of the tail). Then∑
y≥k∗
P2(Yt = y; p) =
∑
y≥k∗
C2p(1− p)y = 1− A =⇒ C2 = (1− A)(1− p)−k
∗
.




P2(Y (i)t = yi; p)
]




The MLE is found by maximizing the likelihood L(p). Setting ∂p logL(p) = 0 we
solve to find the MLE
p̂ =
N∑N
i=1 yi +N(1− k∗)
.
The power-law case is analogous. There C1 =
1−A
ζ(ψ,k∗)
, where ζ is the Hurwitz zeta
function [26]. No closed form expression is found for the MLE and instead we
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have the approximation [17] for large k∗










We must select k∗ as the start of the tail behaviour of each of the given
distributions. As we assume all data is drawn from the tail, we choose k∗ = min y.
Note we also assume the weight of the distribution prior to entering the tail
behaviour, A, is the same in both cases.
2.5.2 Likelihood analysis results
The estimates of the log-likelihood ratio for each dataset is shown in Figure 2.5a.
We see that 19 of the 21 dataset return the power-law hypothesis as more plausible
(R̂ > 0) than a geometric tail.. Assuming a power-law distribution, the maximum
likelihood estimates for the exponent ψ for each dataset are given in Figure 2.5b.
For 20 of the 21 datasets we find the point estimate of the power-law index, ψ̂, lies
in [1, 2], with an average of 1.57. The outlier comes from the smallest dataset (3
metastases). Due to the small sample size of our datasets and the high variance
in the distribution, we do not derive confidence intervals via normal distribution
approximations. Instead we show the normalised log-likelihood, logL(ψ)/L(ψ̂),
for our best dataset, with N = 30, in Figure 2.5c, where L(ψ) is the likelihood
function. Also, following [43], we demonstrate the likelihood interval defined as
I(ψ) = {ψ : log L(ψ)
L(ψ̂)
≥ −2}.
If a large sample size was possible this interval would correspond to a 95.4%
confidence interval. For the dataset with N = 30 we numerically determined
I(ψ) = [1.295, 1.616], illustrated as the domain between the vertical bars in Figure
2.5c.
We continue to assume the data is drawn from a power-law decaying distribution.
The results of Sections 2.3.1 and 2.3.2, imply that given the data is sampled from
a distribution with a power-law decaying tail, the exponent of the decay conveys
information on the relative growth rate of the primary to the metastases. As
the estimated exponents are all greater than 1, which would be the exponent for
subexponential primary tumour growth, we focus on the case where the primary
tumour grows exponentially. From Corollary 2.1 we see ψ̂− 1 is a point estimate
43
(a) Likelihood ratio R̂ for
each dataset. Points
above the horizontal line
suggest dataset is from
a power-law distribution
over a geometric distri-
bution.




function for first best set.
Vertical bars show the
likelihood interval.
Figure 2.5 Likelihood analysis results: Patients are sorted left to right by
number of metastases with patient 1 having 30 mets to patient 21
having 3. Hence values to left of figures are more significant.
of γ/λ, the ratio of the primary growth rate to the metastases growth rate. As the
average estimate of this growth rate ratio is 0.57, under the exponential growth
model, the metastases grew almost twice as fast as the primary tumours. Note
that each patient may have different primary and metastasis growth rates, i.e.
we do not assume a uniform δ across the patients. We can compare our estimate
with previous studies who have reported estimates for the ratio of the primary
growth rate to the metastatic growth rate. For melanoma [15] reports 0.44 while
[78] gives 0.66 for epidermoid cancer types. These values are computed as the
average primary growth divided by the average metastatic growth, whereas we
give the average of the primary growth rate to the metastatic growth rate. We
can see that our estimates are reasonable.
2.6 Discussion
Before giving some concluding remarks we contrast the work presented above
with two contemporaneous studies.
44
Time-dependent rate parameters
Two recent works [42, 84] have also investigated the impact of relaxing the
assumption of exponential growth in Luria-Delbrück models of mutant generation.
In both cases they considered the case where all rates in the system are
multiplied by a time-dependent function, say z(τ). This is relevant in the
scenario where both the wild-type and mutant populations have their growth
restricted simultaneously by environmental factors, for example exposure to a
chemotherapeutic agent. We observe that under a change of timescale this system
is equivalent to our setting with exponential wild-type growth. This is due to the
following argument.














Mutant clones are now initiated at a rate νz(τ)nτ and we let K̂t be the number





and define the new timescale as r(τ) = F−1(τ). The expected number of












































Thus the initiation of mutant clones is equivalent to the exponential wild type
case. We now turn to mutant growth.
Let Ẑt be the size of a mutant population governed by the birth-death process
with time-dependent rates. Once initiated, the size distribution obeys the forward
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Kolmogorov equation for time-dependent stochastic mutant proliferation
d
dt
P(Ẑt = k) = z(t)(k − 1)P(Ẑt = k − 1)
+ βz(t)(k + 1)P(Ẑt = k + 1)− (1 + β)z(t)kP(Ẑt = k).
Similar to the initiation process, the chain rule shows that the forward Kol-
mogorov equation for Ẑr(t) is equal to that of the time independent linear birth
death process. Thus, under a time-rescaling, all dynamics are equivalent to the
system with exponential wild-type growth and stochastic mutant proliferation
with constant birth and death rates, as studied in this chapter or in [51].
2.6.1 Shortcomings and future work
From both a biological and mathematical viewpoint, there are several aspects
of this study which should be examined further. We will use the approximate
model of Section 2.1.4 to illustrate future areas of interest. Recall in this setting,
mutant clones grow deterministically and so clones may take values in [1, eλt]
Firstly, while the asymptotic distribution has been explored for clones of a fixed
size, and of size around eλt (Sections 2.3.1 and 2.3.2), these might not be the
most relevant limits. For example, taking power-law wild type growth nτ = τ
ρ,
we see that if we examine the distribution around y = eaλt for 0 < a < 1 we have
P(Y ′t > y) = P(eλ(t−T







This implies that (Y ′t )
1/(λt) which takes values in [1, e] possesses a proper
probability distribution for all t. Exploring this observation might lead to more
succinct proofs but should not change the general conclusions of the above.
Relatedly, in the context of cancer one of our motivations for considering wild
type growth other than exponential was that primary tumours growth will be
restricted eventually due to environmental constraints. However this will also be
true of large enough metastases. A size dependent branching process could be
considered, but in light of the insight that has been provided in the exponential
case, a first step would be to have mutant growth follow a generic deterministic
function gτ . For example, when both the wild-type and mutant populations grow
deterministically as τ ρ, we see that for large times the clone size distribution still
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displays a power-law tail, limt→∞ tfY ′t (y) =
ρ+1
ρ
y1/ρ−1. It would be interesting to
explore how general power law tails are in growing populations seeding growing
populations.
A further biological criticism is the fact that each clone has the same birth and
death rates. However the growth rates of individual metastases are likely to be
dependent on the genotype of the founding cell and its local environment. For
example the per day growth rates of metastases given in [78] yield a 95% range of
0.0013-0.0866 against a mean of 0.0107. While this data pools the growth rates
across patients, we still expect fluctuations at the patient level. To address this
we could modify our process such that we associate an iid real valued random
variable Λi for each arrival in the non-homogeneous Poisson process (Kt)t≥0. For
a fixed death rate, the birth rate of each clone would then be δ + β + Λi. This
is similar to the model of [28], where the impact of random fitnesses on the total
number of mutants was explored. The exploration of this model is left for future
work.
For the metastasis application of this chapter, it was assumed that metastases
were initiated at a rate proportional to the primary tumours size. Implicitly
we are supposing all (or a time independent fraction) of the primary cells can
lead to metastases. However, it is often thought that cells in the primary
tumour must acquire a mutation to become ‘metastatically enabled’, and it
is only this subpopulation that seeds the metastases. While some models of
metastases [25, 37] consider this extra complication, we have not included it for
two reasons. Firstly, the evidence for whether a metastatically enabling mutation
exists currently appears inconclusive [49, 85]. Secondly if such a mutation is
required, for exponential primary growth, the resultant subpopulation would also
eventually grow exponentially. For similar reasons, we do not treat the case of
metastases initiating further metastases
A technical criticism regarding the metastasis application is our use of the
likelihood ratio as a model selection tool. While the approach is intuitive and
it is that recommended in [17], it may be simpler to place the model selection
question within a Bayesian framework. The advantage of this approach would be
to allow confidence intervals to be estimated via simulation for the corresponding
quantity to the likelihood ratio. This was avoided here, as the confidence intervals
for the likelihood ratio are based on large sample asymptotic normality which was
not applicable, although a simulation based approach conditional on the MLE
estimates would be possible.
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A different application of interest concerns the sizes of clones of mutated skin
cells, where the mutation is induced by exposure to ultraviolet radiation. This
was the setting considered in [56]. Prolonged exposure to UVB radiation leads
to the initiation of p53 mutant clones (PMC), that is colonies of cells lacking
sufficient, functional amounts of the protein p53, which is known to suppress
cancer initiation. The observed size distribution of PMCs is remarkably similar to
that shown Figure 2.2 at short times with a constant wild type growth function.
Namely a power-law with approximate exponent -1 was found, followed by an
exponential cut off. Hence, as was concluded in [56], a model of stochastically
(birth-death process) growing clones initiated at a constant rate is consistent
with the data. Due to Corollary 2.1, this will also be true for subexponential
type initiation of clones, for a large enough time. This does not change the
conclusions of [56], whose main aim was challenging that clones grew according
to a power-law, which would result in a different PMC size distribution. However
it does indicate further applications for some of the work presented here.
2.6.2 Concluding remarks
In this study we focus on the size distribution for mutant clones initiated at a rate
proportional to the size of the wild-type population. The size of the wild-type
population is dictated by a generic deterministic growth function and the mutant
growth is stochastic. This shifts the focus from previous studies which have
mostly been concerned with exponential, or mean exponential, wild-type growth,
and considered the total number of mutants. Results for the total number of
mutants are, however, obtainable from the clone size distribution.
Motivated by their extensive use in applications the generating function for the
special cases of exponential, power-law and logistic wild-type growth was given.
Regardless of the growth function, the mass function is monotone decreasing and
the distribution has a cut-off for any finite time. This cut-off goes to infinity for
large times and is often enormous in practical applications, hence we focused on
the approach to the cut-off.
We found that the clone size distribution behaves quite distinctly for exponential-
type versus subexponential wild-type growth. Although the probability of finding
a clone of any given size stays finite as t → ∞ for exponential-type growth,
it tends to zero for subexponential type. Despite these differences, with an
appropriate scaling, for a large class of growth functions we proved that the clone
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size distribution has a universal long-time form. This long-time form possesses a
power-law, heavy tail which decays as 1/k for subexponential wild-type growth,
but faster for exponential-type growth. This can be intuitively understood as the
tail distribution represents clones that arrive early, and the chance that a clone
is initiated early in the process is larger for a slower growing wild-type function.
Hence we expect a heavier tail in the subexponential case.
An underlying motivation for this work is the scenario of primary tumours seeding
metastases in cancer. From our theoretical results it was predicted that regardless
of the primary tumour growth, a power law tail was expected in the metastasis size
distribution. As a first step to explore this, likelihood analysis was applied to a
dataset of metastasis sizes. Asking whether the data was more likely sampled from
a power-law or exponentially decaying distribution, the power-law was returned
as more plausible for 19 of 21 datasets. This allowed estimation of the relative
growth rate of primary tumour to the metastases, which was approximately 0.57
(metastases grew almost twice as fast). For medical applications, there are
superior methods to obtain this quantity. For example, tracking the growth
of primary tumours and metastases in images. However, given the array of
complexities not considered by our model, that the general prediction of the
model (power-law tail in the clone size distribution) was not inconsistent with
the data gives some support to the reasonableness of our approach.
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Chapter 3
Competing Pathways in Growing
Populations over Fitness Valleys
3.1 Introduction and Model
3.1.1 Introduction
In the previous chapter we considered the clone size distribution of mutants
initiated from a wild type population. A single transition was required to alter
wild type cells into mutants. In this chapter we discuss the natural extension
where the cell type of interest, mutants in Chapter 2, is an arbitrary number of
transitions from the initial cell type.
Transitions might be the acquisition of (epi)genetic alterations or the migration
into new environments. Suppose we have a cellular state of interest, for example;
a given genotype, a spatial location, or a combination of both. Will this state ever
be reached? If it is, when is it reached? And by which sequence of intermediate
states?
Consider the example illustrated in Figure 3.1. Each vertex represents a cellular
type, in this case its resistance profile. The edges represent cell transitions via
mutation upon replication. How long does it take for multidrug resistance to
emerge? En route, is resistance to drug A or drug B more likely to arise first?

























Figure 3.1 Motivating example: consider a population of growing cells. Each
vertex represents a cell type and cells can mutate to acquire
resistance. Starting from one sensitive cell that can replicate, die or
mutate, how long does it take to traverse the graph until multidrug
resistance emerges? Is resistance to drug A then B more likely than
the converse?
where the meaning of transition is determined by context. A common method
is to model the growing population as a continuous time birth-death (branching)
process. In this chapter we offer a detailed treatment of this model when all the
intermediate states have reduced reproductive ability (fitness). We focus on this
due to applications in cancer and bacterial modelling.
Our main contribution is to provide simple intuitive formulas that answer the
questions posed above for a moderately general setting. These formulas show
explicitly the contribution of the model parameters, e.g. transition rates and
fitness reductions, which allow them to be probed for biological insight. This
provides relationships which might be difficult to deduce from simulations alone.
The outline of this chapter is as follows. Firstly, we precisely describe the process
we consider in Section 3.1.2. We next appeal to recent progress in branching
process theory [47] in order to understand the population growth of intermediate
types. This is then used to characterise the time it takes for a population of a
given type to arise. Both our accounts of the population growth and time involve
the entries of an eigenvector of a given matrix. A fuller picture of the impact
of all the system’s parameters becomes apparent when we specialise our graph
to be acyclic which we do in Section 3.2.3. Continuing with the acyclic setting,
we follow this by considering which sequence of transitions leads to this target
population arising, in particular the probability of a given sequence is derived.
How these results carry into the cyclic setting is next considered and we remark
on some extensions to the initial model for which our discussion still holds. In
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section 3.3 we demonstrate the utility of our results with some applications. The
scenarios of imperfect drug penetration and the orderings of resistance conferring
mutations are considered at length. We hope this exemplifies how readers may
apply the results of Section 3.2. We close with a concluding discussion.
3.1.2 Model
We start by defining the specific framework our results hold for.
Our model is a specific form of multitype branching process [6] in which each
population will evolve according to a Markovian linear birth-death process with
transitions. We will assume each population is comprised of cells. As a conceptual
framework we associate the multitype branching process with a simple, finite,
rooted, directed, graph G = (V,E) containing N vertices (N = |V |). Labels of
the vertices take values in {1, . . . , N} and E is a subset of the set of ordered
pairs {(i, j) : i, j ∈ V, i 6= j}. We shall often refer to vertex 1 as the root and
vertex N as the target. Each vertex is reachable from the root and the target
is reachable from any other vertex. We further assume the root is a source
vertex and the target vertex is a sink. Letting the set of incoming neighbours
for vertex i be N−(i) = {k ∈ V : (k, i) ∈ E} and the set of outgoing neighbours
N+(i) = {k ∈ V : (i, k) ∈ E}, the previous assumption is N−(1) = N+(N) = ∅.
Each type in the branching process is uniquely mapped to a vertex, and so the
number of types is N . Hence any cell may be described by its type or the vertex
associated to that type.
Take any cell at vertex x. We assume this cell gives birth at rate α(x), dies at rate
β(x) and transitions (at replication) to a cell of type y at rate ν(x, y) if edge (x, y)
is contained in E. The growth rate of type x will be denoted λ(x) = α(x)−β(x).
The parameters associated with the type 1 population feature prominently and
so for convenience we let α = α(1), β = β(1) and λ = λ(1). All cells are
independent. We will focus on the setting where the type 1 population is the
most fit and has positive growth rate. Therefore, we henceforth assume that
λ > 0 and for 2 ≤ x ≤ N − 1, λ(x) < λ. We do not specify the relative fitness
of the type N population, but in most applications λ(N) > 0. The cell level
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dynamics may summarised as
(x)→

(x), (x) rate α(x)
∅ rate β(x)
(x), (y) rate ν(x, y) if (x, y) ∈ E
where (x) represents a cell of type x and ∅ symbolises a dead cell. At a population
level, the number of cells of type x at time t will be denoted Zx(t). We shall
always assume Zx(0) = zδx,1, where δx,y is the Kronecker delta function. That
is we initiate the system with only type 1 cells, at a quantity z. The population
growth of the initial and intermediate types is crucial and so the notation Z(t) =
(Zx(t))1≤x≤N−1 will be used.
We have two primary questions. The first is, having initiated the system with
z type 1 cells, how long does it take for the population at the target vertex to
arise? That is we concern ourself with the distribution of
T = inf{t ≥ 0 : ZN(t) > 0}. (3.1)
Now assuming that the target vertex is populated by a founding cell, we ask from
which path through the graph G did this founding cell come? This gives rise to







Figure 3.2 Example of the process when N = 8. Vertices represent cellular
types. Cells of type x can transition to type y if the edge (x, y)
exists. Starting with cells at the root vertex, how long until the target
is populated? Is the blue or red path more likely to initiate the target
population?
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vertex, which we aim to characterise. This second question is more precisely
formulated in Section 3.2.4, but is also illustrated in Figure 3.2.
Often a slightly modified set of questions considered, where instead we wait for
the first type N individual to arise whose progeny does not ultimately go extinct.
If this is the setting of interest then the entirety of the discussion below holds
under the minor alteration that the transitions rates into vertex N should be
mapped ν(x,N) 7→ ν(x,N)λ(N)/α(N) for x ∈ N−(N). This is as λ(N)/α(N)
is the probability of non-extinction for a population initiated with a single Nth
type cell (see (1.8)). We would also like to stress that multiple types can exist
at any time, contrasting the often studied case of strong selection weak mutation
regime for a fixed size population [34].
3.1.3 A first approximation: deterministic growth for N = 2
As in Chapter 2, before proceeding to a discussion of the full model as given
above, we take a short digression to discuss a simpler model. In particular, let us
consider the case when N = 2, that is there are only two vertices and so we only
wait for the first mutation from the initial population. Further, let us suppose
that the type 1 population grows deterministically as Z ′t = e
λt (as in Chapter
2, we will use the same variables as given above but with primes to indicate we
consider the reduced model). Transitions from the type 1 population to the target
population occur at rate ν(1, 2)Z ′t. Note this is exactly the initiation process of
mutants considered by Luria and Delbrück [62] as discussed in Chapter 1.
In this setting, as the target is initiated as a non-homogeneous Poisson process,














The above distribution is of the Gumbel class, and so we can obtain the mean of
T ′, but instead note that, for fixed ν(1, 2), it is only when ν(1, 2)eλt ≈ 1 that T ′
is likely to occur. In fact, from direct computation, we see that
lim
ν(1,2)→0
P(T ′ − µ′ > t) = e−eλt/λ, where µ′ = λ−1 log[ν(1, 2)−1]. (3.2)
Hence T ′ is concentrated around the variable µ′. A similar scaling will be
presented for the more complex model.
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In the full model, when we turn to which sequence of transitions occurred (the
second question from the previous section) the following observation provides the
intuition. Observe that we can informally state (3.2) as, for small ν(1, 2),





In turn, this implies
P(eλT ′ > t) ≈ exp (−ν(1, 2)t/λ) .
Thus by rescaling time, the time from the root vertex population to the target
population arising is approximately exponentially distributed. Here there is only
one transition that can occur, and hence no questions about the orderings of the
transitions is possible. However in the full model, by arguing in a similar manner
to the above, the scaled time it takes for a particular sequence of transitions
will again be exponential. From this, which sequence of transitions occurs first
may be deduced by the orderings of exponential random variables, which is well
studied.
3.2 Results
Where possible, we aim to present our results in tandem with heuristic
derivations, similar to that of the previous section, to convey the general idea. Key
is the understanding of the asymptotic behaviour of the initial and intermediate
population Z(t) at long times.
3.2.1 Long time population size
In the above discussion of the reduced model , the distribution of T ′ was accessible
due to our assumption that the root population grew deterministically and
exponentially. Returning to the full model, the target vertex is seeded by the
neighbouring populations, whose growth is stochastic. However the asymptotic
theory given in [47], whose relevant statements we give below, shows that the
long time behaviour of the initial and intermediate population Z(t) is exponential
growth with a random amplitude. Therefore the situation in the full case is similar
to that considered in the reduced model.
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The main purpose of this subsection is to present the required statement from [47].
However to do so we first introduce some further notation and then give a short
lemma detailing restrictions on G such that the asymptotic result is guaranteed
to hold.
As defined above the process Z(t) = (Z1(t), . . . , ZN−1(t)) is a multitype branching
process, and we further specify that each Zi(t) be right-continuous. It will become
apparent that the stochasticity in Z(t) is controlled by the type 1 population. As
vertex 1 is a source vertex, and thus no type transitions into a type 1 cell, the
long term behaviour of Z1(t) is as described in Section 1.3.1, which we restate
here in a form convenient for our later discussion. Recall that z is the initial





−λt = W a.s.







where χi ∼ Bernoulli(λ/α), ξi ∼ Exponential(λ/α) and are independent.
In terms of notation, for real random variables X, Y , that X
d
=Y means P(X ≤
x) = P(Y ≤ x) for each x ∈ R.




λ(i) j = i
ν(j, i) if (j, i) ∈ E
0 otherwise.
A controls the mean behaviour and as is seen from the forward Kolmogorov
equations, or Lemma 9.2 in [47], we have
E[Z(t)] = exp(At)ze1.
The notation ei is used for the (N − 1)× 1 vector with ith entry equal to 1 and
0 otherwise. Also note that the off diagonal elements of the transpose of A are
positive whenever the corresponding element of the adjaceny matrix of G is one.
In order to use results from [47], we wish to discuss the case when the largest
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real eigenvalue of A, λ∗, is simple (i.e. has algebraic multiplicity 1) and equal
to λ. Below we give two sufficient conditions for this to be true. The second is
motivated by applications when typically all transition rates are small.
Lemma 3.2. Sufficient conditions such that λ∗ = λ and is simple are: 1) G is
acyclic. 2) For all 2 ≤ i ≤ N − 1, λ(i) +
∑
k∈N−(i) ν(k, i) < λ.
Proof. 1) As G is directed and acyclic, a relabelling of the vertices exists such
that the underlying adjaceny matrix of the relabelled graph is upper triangular.
This is shown in Appendix B. We use this relabelling with vertex 1 as first in
the labelling, π. Thus π is a permutation of {1, . . . , n} with π(1) = 1. The






 , PT1 = [eπ(1), · · · , eπ(n)] .




By Lemma B.2 A′ is lower triangular and has the λ(i) as diagonal elements. Thus
λ is the largest eigenvalue of A′. As A and A′ are similar matrices, and hence
share eigenvalues, we can conclude the statement.
2) By considering the left eigenvector eT1 , λ is indeed an eigenvalue. We now
demonstrate all other eigenvalues have real part smaller than λ. Observe that
the assumed condition implies the bound on the row sums
N−1∑
j=1
ai,j < λ. (3.3)
AsA is reducible (due to the root being a source vertex) there exists a permutation









RM,1 . . . RM,M

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with each submatrix Ri,i square and irreducible and 2 ≤ M ≤ N − 1 (see [86]
section 2.3). The eigenvalues of A comprise λ and the eigenvalues of the Ri,i.
For any of the Ri,i let r
(i)
j be sum of the jth row of Ri,i. By Gershgorin’s Disc
Theorem ([86] Theorem 1.5) the real part of the eigenvalues of Ri,i are bounded
by maxj{r(i)j }. Further, the bound (3.3) is preserved under permutations and so
each r
(i)
j < λ. As this holds for each Ri,i the claim is shown.
Henceforth we assume either of the conditions given in Lemma 3.2 hold and thus
λ∗ = λ and is simple. Due to this assumption, results of [47] show that the type
1 cells drives the entire population growth. To state this result, we introduce the
vector ψ with




Now let ũ, ṽ be the left and right eigenvectors of A corresponding to λ, scaled
such that
ψ · ṽ = 1, ũ · ṽ = 1. (3.5)
Note, from the structure of A, only the first entry of ũ is non-zero, that is ũi > 0
if i = 1 and 0 otherwise. Further let
φx = ũ1ṽx. (3.6)
Then the following holds.
Theorem 3.1 (Janson [47]). With W as in Lemma 3.1,
lim
t→∞
e−λtZ(t) = W (φx)
N−1
x=1 a.s.
Proof. We demonstrate how to apply the result in [47] to our setting. From
Theorem 3.1 in [47], with probability one
lim
t→∞
e−λtZ(t) = Ŵ ṽ
where Ŵ is a non-negative random variable, with as yet unknown distribution.
However from Lemma 3.1 almost surely e−λtZ1(t)→ W , with the distribution of
W given in the lemma. This implies Ŵ = W/ṽ1 = ũ1W with the last equality
following from (3.5) and that only the first entry of ũ is positive.
It is perhaps surprising that at the scale of eλt the only randomness of the
intermediate types (types 2 to N − 1) is inherited from the random amplitude of
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the type 1 population. The same result for the case N = 3 was demonstrated in
[16].
W , as given in the above theorem, is positive only when the type 1 population
avoids extinction (almost surely). It will be convenient to define this event and
so we let
S1 = {Z1(t) > 0 for all t ≥ 0}. (3.7)
Immediately from Lemma 3.1 (when W = 0) or (1.8) we have
P(S1) = 1− (β/α)z. (3.8)
Now due to Theorem 3.1, we find that the frequencies of the initial and
intermediate types converge deterministically as detailed in the following.











where the φx are as given in (3.6).
3.2.2 Time until target vertex is populated
We now turn our attention to T , the time at which the type N population
arises, as defined in (3.1). In particular we focus on the distribution of T
when the transition rates into the target are small. For each neighbour of the
target x ∈ N−(N), the vertex x seeds vertex N with intensity, or seeding rate,
ν(x,N)Zx(t). This is similar to the motivating example of the linear birth death
process with mutations discussed in Section 1.3.2. Assume the transition rates
into vertex N are small enough such that when T is likely to occur sufficient time
will have passed that each Zx(t) can be well approximated by its asymptotic form.
Then the seeding rate from vertex x into the target vertex will be approximately
ν(x,N)Weλtφx. Hence we might expect

















The first equality arises as the target vertex is initiated according to a Cox process
and should be compared with the discussion leading to (1.11) in Section 1.3.2.
Note that the final expectation can be computed due to our knowledge of W
provided by Lemma 3.1. To formalise this argument we introduce some further
notation.
In order to ensure the transition rates are small enough such that the asymptotic




i.e. the largest of the transition rates into the target. As ν∗ → 0, T → ∞. To
describe the manner in which T increases in this limit we define






Then the following holds.
Theorem 3.2. Let W be as in Theorem 3.1, then with probability one
lim
ν∗→0



















Then, as for given (Z(t))t≥0 immigration into vertex N occurs as a non-
homogeneous Poisson process,



































Consider the limit of the summands as ν∗ → 0, which results in log(σ−1) → ∞.
As the (Zi(t))i∈N−(N) are independent of (ν(i, N))i∈N−(N), Theorem 3.1 provides
the limit for the first term in the product of each summand. Upon considering
(σ/ν(i, N))−1, we see ν(i, N)/σ <∞ for each i. Hence taking limits across (3.11)






























−1 log(σ−1)) = Weλu a.s. (3.12)
We seek to apply the dominated convergence theorem to the integral in (3.10).
The above convergence implies that for any realisation, we may find x such that
for ν∗ ≤ x ∑
i∈N−(N)
ν(i, N)Zi(u+ λ
−1 log(σ−1)) ≤ 2Weλu
which is integrable over (−∞, t]. If ν∗ > x then σ > 0. Thus the interval
[λ−1 log(σ−1), t] is finite. As each Zi(t) is cadlag, it is bounded over finite intervals.
Hence for all (ν∗, u) the integrand is dominated by an integrable function.










µ = λ−1 log(λ2/α) + λ−1 log(σ−1)
so that we centre appropriately, leads to the first stated result.
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Using a one-step conditioning argument on χ1 and considering the Laplace
transform for a unit rate exponential variable leads to the stated result.
The first statement in the above theorem (3.2) will be key to understanding
the path distribution, discussed in Section 3.2.4, which justifies its prominence.
It may be interpreted as indicating that if time is rescaled and we look at the
distribution of T around µ, an exponential distribution appears. We also remark
that our reason for taking only the transition rates into the target vertex is as
discussed directly under (3.11), namely that the growth of Z(t) is independent of
these transition rates, which allows us to use Theorem 3.1 to show (3.12).
It is natural to consider the distribution of T conditioned that it is finite (we
cannot discuss which path populated the target vertex if T =∞). However it is
technically more convenient to condition on S1, defined in (3.7). The following
proposition states that in many relevant cases, namely large initial population,
low death rate or small transition rates leaving vertex 1 these events are similar.
Below, the superscript c denotes the complement of the set.
Proposition 3.1.
P({T <∞}c ∩ S1) = 0.
P({T <∞} ∩ Sc1) ≤

O((β/α)z), β → 0
O((β/α)z), z →∞




Proof. As P({T < ∞}c ∩ S1) = P(T = ∞|S1)P(S1) and P(S1) > 0 we initially
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demonstrate
P(T <∞|S1) = 1. (3.14)
Firstly recall that observation that with W as in Lemma 3.1, up to null events,
{W > 0} = S1. Now T is the first arrival in a Cox process with intensity∑





with probability 1 on S1. Observe that (3.15) is true as, by Theorem 3.1, for any











As each φx > 0, due to each entry of ṽ also being positive [47], the right hand
side of the above inequality is infinite a.s. on S1 which gives (3.14). It remains
to bound P({T <∞} ∩ Sc1).
Let us introduce Z∗(t) =
∑
i∈N+(1) Zi(t) and
τ = inf{t ≥ 0 : Z∗(t) > 0}.
Note that we cannot hope to populate the target vertex without Z∗(t) becoming
positive. Therefore, {T <∞} ⊆ {τ <∞} which implies
P({T <∞} ∩ Sc1) ≤ P({τ <∞} ∩ Sc1).
Hence our interest turns to the right hand side of the preceding inequality. The
distribution of τ is invariant to the growth of the types i ∈ N+(1), and so
we let α(i) = β(i) = 0 for such i. The process (Z1(t), Z
∗(t)) is a two-type
branching process where cells of the second type (that contribute to Z∗(t)) simply
accumulate. For now assume z = 1. As
P({τ <∞} ∩ Sc1) = (1− P({τ =∞}|Sc1))P(Sc1) (3.16)
= P(Sc1)− lim
t→∞
P(Z1(t) = 0, Z∗(t) = 0),




We introduce the generating functions
G1(x, y, t) = E[xZ1(t)yZ
∗(t)|(Z1(0), Z∗(0)) = (1, 0)]
G∗(x, y, t) = E[xZ1(t)yZ∗(t)|(Z1(0), Z∗(0)) = (0, 1)].






1 + β + ν1G1G
∗ − (α + β + ν1)G1.
By solving this equation (separation of variables with a partial fraction decom-
position), and using the initial condition we find
























(1 + q1 + ν ′1)
2 − 4q1
)
where q1 = β1/α and ν
′
1 = ν1/α. Observe that (1 + q1 + ν
′
1)
2 − 4q1 > (1 − q1)2
which implies r2 − r1 < 0. Hence
lim
t→∞
P(Z1(t) = 0, Z∗(t) = 0) = r2.
We now have expressions for the final terms in (3.16) for z = 1. For z ≥ 1, we
can use independence, and this leads to
P({τ <∞} ∩ Sc1) = qz1 − rz2.
By examining the leading order with respect to the relevant variables we can
conclude.
However we note that if we instead wish to look at the case when the
vertex N population arises and does not go extinct then P(T = ∞) =
P(All populations go extinct). The probability of population extinction is known
to be given by an implicit equation involving the offspring distribution’s
generating function. This was the approach taken by [45]. The approximate
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solution for small transition rates was derived and agrees with the result presented
above.
The above proposition yields an approximation for the probability that the type
N population will ever arise, that is
P(T <∞) ≈ P(S1) = 1− (β/α)z. (3.17)
The distribution of T given S1 can now be stated.
Corollary 3.2. With the notation of Theorem 3.2,
lim
ν∗→0
P(λ(T − µ) > t|S1) =
[λ/α(1 + et)−1 + β/α]
z − (β/α)z
1− (β/α)z
Proof. Starting from the first statement in Theorem 3.2, we only need apply







where ξ′i are rate one exponential variables, and B ∼ Binomial(z, λ/α),
independent of all ξ′i. Conditioning on S1 ensures that B > 0. Thus as in











(1 + et)−B|B > 0
]
.
The binomial theorem leads to the stated expression.
We remark that while Theorem 3.2, is not conditional on S1, the rare trajectories
when Sc1 occurs (the type 1 population dies) and T <∞ are not captured by the
current scaling. This is due to the fact that in these cases T will be much larger
than µ.
From the above we can see that T is concentrated around the variable µ. The
corollary below states that when we initiate with one cell, and the type 1
population survives, µ is the asymptotic median time to reach the target. If
z > 1 the median is instead µ minus a z-dependent term.
Corollary 3.3. Let t1/2 be the median time for the type N population to arise,
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conditioned on S1. That is t1/2 satisfies







|t1/2 − µ− h(z)| = 0
where
h(z) = λ−1 log
(
λ/α




This also implies t1/2 ∼ µ+ h(z). Regarding h(z) we have






Proof. We firstly note, as is apparent from the cumulative distribution function





= P(λ(T − µ) > λ(t1/2 − µ)|T <∞).
Taking the ν∗ → 0 limit we find λ(t1/2 − µ) → x, where the convergence is
guaranteed as both t1/2, µ are monotone increasing. Further, from Corollary 3.2,
the limit x satisfies















21/zλ/α− 2 αλz (1 + (β/α)z)1/z + 2 1z+ αλzβ/α
(1 + (β/α)z)1/z − 21/zβ/α
.
Expansions on the numerator and denominator show that d(z) is O(z−2). Then
λh(z) = log(2
α
λz − 1 + d(z))
= log(2
α




+ . . .
As (2
α
λz − 1)−1 = O(z) we have shown the claimed asymptotic behaviour.
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3.2.3 Path costs/benefits and the case of acyclic graphs
The sequence (φx)
N−1
x=1 features prominently in both the main results of the
previous section, Theorems 3.1 and 3.2. In applications we wish to have explicit
representations for (φx)
N−1
x=1 to assess the impact of parameters. It will become
apparent that in the setting where G is acyclic, the φx can be written in terms of
the intuitively comprehensible path costs and benefits which we now introduce.
Path costs and benefits
Consider any path from the root to the target vertex. Intuitively, if the transition
rates encountered along this path are larger, the target population will be seeded
from this path quicker. Conversely the smaller the growth rates along this path
are, the target will be reached slower. This motivates the concept of the cost and
benefit of paths which we now define for paths between the root and any vertex.
Let the set of paths between the root and vertex x be denoted P1,x. So that
we can discuss the root we let P1,1 = {(1)}. Any p ∈ P1,x, will be a sequence
p = (p1, p2, . . . , pl, pl+1), where each 1 ≤ pi ≤ N , l is the path length, all pi are
distinct, and p1 = 1, pl+1 = x. Along a path p, let us call the difference between
the growth rate at the root and the vertices encountered the fitness costs. The
path benefit, b(p) and cost, c(p), are defined in terms of the transition rates and




ν(pi, pi+1), c(p) =
l∏
i=2
(λ− λ(pi)) . (3.19)
Throughout the empty product is set to 1.
Path graphs
To see the reason for introducing these quantities let us consider the case when
G is a path graph. Path graphs, or linear graphs, are graphs where every vertex
has indegree and outdegree 1, except vertex 1 (indegree 0 and outdegree 1) and
vertex N (indegree 1 and outdegree 0). An example is shown in Figure 3.3.
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1 2 3 4 5
ν(1, 2) ν(2, 3) ν(3, 4) ν(4, 5)
Figure 3.3 A path graph on 5 vertices
Let the path between the root and the target vertex be denoted p̃. Further let
the first x terms in p̃ be denoted
p̃1:x = (p̃1, p̃2, . . . , p̃x).








In this setting the matrix A from Section 3.2.1 has entries
aij =

λ(i) j = i
ν(i− 1, j) j = i− 1
0 otherwise,
and the vector ψ has entries ψi = α(i)+β(i)+ν(i, i+1) for i = 1, . . . , N −1. We
want a useful representation of the sequence (φx)
N−1
x=1 , which we recall is given in
terms of the entries of the suitably normalised left and right eigenvectors of A.
Because they are easier to work with (i.e. check they indeed are eigenvectors) we
first introduce the unnormalised left and right vectors u′, v′ with entries
u′i =




ν(j − 1, j)
, 1 ≤ i ≤ N − 1
It may be directly verified that these are left and right eigenvectors for A with








The following corollary demonstrates how the results of the previous section on
population growth and time to reach the target simplifies in the path graph
setting.
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Figure 3.4 Illustration of the asymptotic behaviour of the population growth and
the median time until the 4th population arises in a path graph. Here
all transition rates are ν and all fitness costs are ε, as in (3.20)





ν∗ = ν(N − 1, N),
and




Let us explicitly consider the case of equal transition rates and fitness costs, say
ν = ν(j − 1, j) and ε = λ− λ(j). We see for path graphs, asymptotically Zi+1(t)
is related to Zi(t) by a multiplicative factor of
ν
ε
. For z = 1 we have the following

















The first term on the right hand side comes from waiting for the first transition
from the type 1 population, while the second is due transitions between the
remaining types. The first term is distinct as the type 1 growth is the main
cause of stochasticity, as mentioned in the discussion after Theorem 3.1. The
population growth and time until initiation of the type N cells is illustrated for
this case in Figure 3.4.
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Acyclic graphs
We now consider the case where G is acyclic. Representations of the sequence
(φx)
N−1
x=1 are obtainable via algebraic methods, but instead we deduce the same
representations via the concept of vertex lineages. This construction is more
intuitive and will be required when discussing which path the target vertex is
seeded from.
For any existing cell we associate a vertex lineage p = (p1, . . . , pl+1), where each
pi ∈ V and l+ 1 = |p|. This represents the types of cells in a given cells ancestral
lineage. For example we may have a type-2 cell with vertex lineage p = (1, 3, 4, 2).
Each lineage begins with 1 and ends with the present type of the cell. It is clear
a vertex lineage is a path in G of length l. As above we let the set of paths from
vertex 1 to vertex x be P1,x. We denote the number of cells at time t with vertex
lineage p as X(p, t).
The number of cells at a vertex is related to the cells with vertex lineages ending





For any path p, as above we let the first j terms in p be denoted p1:j. The
process (X(p1:j, t))
l+1
j=1 is a multitype branching process, and X(p1:j, t) represents
the number of cells that have progressed to step j along path p. Births occur to
individuals of type i at at rate α(pi), deaths at rate β(pi) and individuals of type
i transition to type i+ 1 at rate ν(pi, pi+1). Thus we may use our results for path
graphs with vertices labelled 1, . . . , l + 1. Hence via Theorem 3.1 and Corollary








where b(p), c(p) are the path benefit and cost given in (3.19) and W is as in
Lemma 3.1.
Analogously to Corollary 3.4 we have the following statement regarding the
growth of the initial and intermediate population types.
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1 ≤ x ≤ N − 1,
b(p), c(p) are the path benefit and cost given in (3.19).
Note that as the empty product is defined to be 1, φ1 = 1. Before giving the
proof of the above corollary we give a needed lemma.
Lemma 3.3. Let A1, . . . , An be events such that P(Ai) = 1 for every i. Then
P(∩ni Ai) = 1.
Proof.



















e−λtX(p, t) = W
 = 1.
Let Ap = {limt→∞ e−λtX(p, t) = W} and use Lemma 3.3 to conclude.
The results of Section 3.2.2 (regarding the time to reach the target) hold also but
they are simpler to state after some further notation has been introduced. This
notation will also be useful for discussing the distribution of paths to the target.
Note that |P1,N | is finite, and so we let
n = |P1,N |.
The elements of P1,N can be enumerated and we use the following notation to do
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so
P1,N = {p(1), . . . , p(n)}.







) be the final transition rates. Note that ν∗ = max1≤i≤n{u(i)}. Then
we have the following.
Corollary 3.7. The results of Section 3.2.2 hold with the explicit representation






As the time to reach the target T is concentrated around µ it is reassuring that
as the path benefits increase, µ decreases, while if the path costs increase, µ
increases.
3.2.4 Path to target
We now consider which path leads to the type N population arising. We expect
paths with higher benefit to cost ratios to be more likely and this is confirmed.
If we only consider the time to reach N along path i, then our result on path
graphs, Corollary 3.4, describes this. Therefore to determine whether the target
is reached first along path i, we must only check if this time is the minimum
compared to the other paths.
Consider p(i) ∈ P1,N and recall that X(p(i)1:j, t) represents the number of cells
that have progressed to step j along path i. If we apply the first statement in




j=1 , then as in the reduced
model of Section 3.1.3, we can deduce that under a time rescaling, the time to
traverse path i is approximately exponentially distributed, conditional on the
population growth along that path. Therefore the question of which path the
target population arises from becomes equivalent to the minimum of a set of
exponential random variables. To state this more precisely, let the time taken to
reach the target via path i be
T (i) = inf{t ≥ 0 : X(p(i)
l(i)+1
, t) > 0}.
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We may have occasion, for instance see Section 3.3.2, to not only ask which path
to the target is fastest, but is one set of paths faster than another. Therefore we
further introduce, for non-empty J ⊂ {1, . . . , n}, the notation
T J = min
j∈J
{T (j)}.
Again the final transition rates along each path will be assumed small and so to
single these out, for path i between the root and the target, we suppose
b(p(i)) = b1(p
(i))u(i).
where again b(p(i)) is the path benefit of path i. Observe that b1(p
(i)) is simply
the product of all but the final transition rates along path i. We will be taking
the limit of small ν∗ and in order to compare the final transitions we henceforth





= κ(i) > 0.
Then the following theorem, which concerns one set of paths populating the target
x time units before another set of paths holds. Note that which set of paths comes
first is dealt with by x = 0.
Theorem 3.3. For non-empty disjoint J1, J2 ⊂ {1, . . . , n} and x ∈ R we have
lim
ν∗→0














Proof. Consider initially the case when n = 2, that is there are only two paths
from vertex 1 to vertex N . These two paths must diverge before N . If the
population growth along these paths until the target vertex is given, then T (1)
and T (2) are the first arrival times in two independent non-homogeneous Poisson
processes. Returning to arbitrary n, to use this fact we define the population







So that we can use this conditional independence, and prior results, we note
P(T J1 + x < T J2|S1) =
E[IS1P(T J1 + x < T J2|(X(t))t≥0]
P(S1)
. (3.23)
We now focus on the argument of the above expectation.
We also know that each T (i) appropriately centred converges. If we centre each
T (i) by the same quantity, then the ordering is preserved. That is, clearly T (1) <
T (2) ⇐⇒ T (1) − µ(1) < T (2) − µ(1) for any µ(1). Let us use the shorthand
notation η(i) = b1(p
(i))/c(p(i)). As T (i) is the target time along the path graph
p(i), Corollary 3.4 gives the appropriate centring. In particular with




P(λ(T (i) − µ(i)) > t|(X(t))t≥0) = exp(−etWλ/α) a.s.
For order preservation (of the T (i)s) we take µ(1) as a common centring of all T (i),
which is possible as T (i) − µ(1) = T (i) − µ(i) + µ(i) − µ(1) and
lim
ν∗→0






Using this, and exponentiating (which again preserves order), leads to
lim
ν∗→0







Recall the T (i) are conditionally independent, and hence convergence of the
marginal distributions implies joint convergence. Therefore for (tj)
n
j=1 with each




















Thus for fixed (X(t))t≥0 the random vector (exp[λ(T
(j) − b1) + λ/α])nj=1 jointly
tends in distribution to a mixture of independent exponential random variables












We see that so long as W > 0, we may use standard results for the exponential
distribution to deduce the right hand side of (3.22). We know, up to null events,
{W > 0} = S1 and hence almost surely
lim
ν∗→0










Coupling the above with (3.23) gives the result.
Thus an approximate distribution appears over the possible paths from the root
to the target, where the probability of a given path is simply proportional to its
benefit to cost. That is, using κ(i) ≈ κ(1)u(i),







In particular we can examine two paths, i and j, and ask along which path is the
target reached faster. The above result then yields the









This expression is intuitively appealing, clearly showing the trade-off between the
relative path benefits and costs.
A perhaps surprising consequence is the impact of paths with costs less than 1.
To illustrate this, let us consider the case depicted in Figure 3.5a with N = 3,
and paths p(1) = (1, 2, 3), p(2) = (1, 3) and ν = ν(1, 2) = ν(2, 3), ν(1, 3) = ν2.
Naively it may be expected that as the product of transition rates along both
these paths are equal, and the first path contains a vertex with a fitness cost, the
second path is more likely. However the result above yields

















(a) Despite the red-dashed path contain-
ing a fitness valley, the type 3
population is more likely to arise via
this path. See (3.25).
(b) Monte Carlo simulations of system
in (a) vs theory (3.25). Parameters
α = 0.9, β = 0.3, λ = 0.6, α(2) =
0.2, β(2) = 0.4, λ(2) = −0.2, ν =
0.1, runs = 250.
Figure 3.5 Crossing valleys can be faster.
for small ν. Thus the first path is more probable, i.e. P(T
(2)>T (1))
P(T (1)>T (2)) > 1, if λ−λ(2) <
1. That crossing a fitness valley can be faster is also confirmed by simulation, as
is shown in Figure 3.5b. Note that for the simulation ν > 0.1α, demonstrating
that for certain situations ν need not be very small for the above to be a good
approximation.
3.2.5 Cyclic graphs and extensions
In Sections 3.2.3 and 3.2.4 it was demonstrated that the time until the target is
populated and the path distribution have explicit representations in terms of the
path benefits and costs. In this section, we allow for cycles in G and demonstrate
that Theorem 3.3 holds for finite length walks. Further when transition rates are
small over all edges, the target vertex is populated via a path. We follow this by
two remarks on extensions of the model for which our results hold.
Cyclic graphs
Suppose G is as before, but without the acyclic assumption. For cyclic graphs
in place of P1,N we must consider W1,N , which we define to be the set of walks
between the root and vertex N . The definition of vertex lineages holds identically
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for walks. Therefore for w ∈W1,N we let
Tw = inf{t ≥ 0 : X(w, t) > 0} (3.26)
where X(w, t) is as given in Section 3.2.3. Here we show that so long as the
number of transitions between vertices is finite, which corresponds to finitely
many back transitions, we may map a graph containing cycles to an acyclic one
and then use the results given above.




1,N = {w ∈W1,N : |w| ≤ i}.
Further for a graph G = (V,E), let the vertex parameters be the birth and death
rates associated to the vertices of G and the edge parameters the transition rates
associated with the edges.
Proposition 3.2. For a given graph G = (V,E) with associated vertex and edge
parameters and fixed i ≥ 1, we can construct an acyclic graph G′ = (V ′, E ′)
(dependent on i), which coupled with appropriate vertex and edge parameters,
permits a bijection g : W
(i)





where T ′ is defined as in (3.26) but with the process on G′ with its associated
parameters.
Before giving the proof we briefly demonstrate this on the graphs shown in Figure

















1,N = {(1, 2, 4), (1, 2, 3, 4), (1, 3, 4), (1, 3, 2, 4)}.
It is clear these may be mapped to the paths in G′
P′1,|V ′| = {(1, 2, 6), (1, 2, 3, 6), (1, 4, 6), (1, 4, 5, 6)}.
Further T(1,2,4)
d
=T ′(1,2,6) so long as the transition rates associated with edges (1, 2)
and (2, 4) on G are equal to the rates with (1, 2) and (2, 6) on G′ and that the
birth and death rates at vertices 1 and 2 are equal in both cases.
Proof of Proposition 3.2. To avoid cumbersome notation and as the idea is
illustrated in Figure 3.6 we sketch an algorithm. We enumerate the set
W
(i)
1,N = {w(1), w(2), . . . w(M)}, where M = |W
(i)
1,N |. Again we use the notation
l(j) for the length of the jth walk, that is l(j) = |w(j)| − 1. The graph G′ is
constructed iteratively. Let V ′1 = {1, 2, . . . , l(1), N ′}, where N ′ is a placeholder
and will ultimately be |V ′|. Similarly E ′1 = {(1, 2), . . . , (l(1), N ′)} and p(1) =
(1, 2, . . . , l(1), N ′).
Then for each further w(j), 2 ≤ j ≤ M, from the previously considered walks
select the walk that w(j) ‘agrees with the longest’, say w(k), 1 ≤ k < j. If w(j)
and w(k) agree up until their mth element, and l(j) − m > 0 then add l(j) − m
elements to V ′j−1 (new vertices starting with |V ′j−1|). This creates V ′j . Denote the


















′). This creates Ej. For p




1:m and then add the
new vertices of V ′j , and terminate the path at N










Figure 3.7 Walks containing cycles can be faster. The walk of length 4 that
traverses the red edges with transition rate ν2 can still be faster than
the length 2 path. See (3.27).
agrees with w(k) until its final element) let V ′j = V
′
j−1 and add the edge (p
(k)
m , N ′)
to E ′j−1. Then p
(j) is equal to p
(k)
1:m concatenated with N
′. Finally our constructed
graph is G′ = (V ′, E ′) = (V ′M, E
′
M) with N
′ = |V ′|.
Identifying g(w(j)) = p(j), we see that if w(j), w(k) agree until their mth element
then so also will g(w(j)), g(w(k)), but after this the paths diverge. We further
require that the birth and death rates for the population type represented by the
kth element of w should be the same as the kth element of g(w). Similarly for
the transition rates between the kth and k + 1th element of w and g(w).





Further for a set of walks W
(i)
1,N , Theorem 3.3 holds but now with the walk benefit
and costs, defined analogously to the definition given in (3.19).
We immediately use this to explore the concept of walks (with cycles) or paths
seeding the target. Consider the graph and edge parameters displayed in Figure
3.7. Let p = (1, 2, 4) and w = (1, 2, 3, 2, 4). Despite the extra length, by using
the above proposition with Theorem 3.3, for small ν1 we see













Thus the walk may be faster.
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However, the following result demonstrates that when the transition rates between
vertices are small, the first initiation of the target is dominated by the paths, as
opposed to walks containing cycles, which offers a secondary justification for
mainly focusing on acyclic graphs. To state the result let us define q : W1,N 7→
P1,N as the operation reducing walks to their respective paths. This may be
accomplished recursively by searching for the first cycle in w and replacing this
with the first element in the cycle. Then repeating the same procedure on the
reduced walk until it is a path. This operation is the same as that which maps
trajectories to their corresponding trajectory class in [80]. Further, for p ∈ P1,N
let
W(i)[p] = {w ∈W(i)1,N : q[w] = p, w 6= p}
that is the walks of length at most i− 1 which when reduced to paths are p, but
excluding p itself. Then with
νmax = max{ν(i, j) : (i, j) ∈ E}
we have the following.






P(Tp < Tw|S1) = 1.
Proof. We construct an acyclic graph with appropriate vertex and edge parame-
ters as in Proposition 3.2 and use the mapping g from there with domain W
(i)
1,N .
As before let P′1,|V ′| be the codomain of g. Then for path p ∈ W
(i)
1,N and walk
w ∈ W(i)[p], g(p), g(w) ∈ P′1,|V ′|. Note due to the manner in which the edge
parameters are chosen {ν(i, N) : i ∈ N−(N)} = {νi,|V ′| : i ∈ N−(|V ′|)} and
hence ν∗ remains unchanged. Similarly νmax is unchanged. Therefore,
lim
ν∗→0
P(Tp < Tw|S1) = lim
ν∗→0
P(T ′g(p) < T ′g(w)|S1).
Furthermore each vertex and edge in p is also present in w. Hence the benefit of
g(w) satisfies b(g(w)) = b(g(p))b̃(g(w)) where b̃(g(w)) is the product of transition
rates along the edges existing in cycles in w. Define c̃(g(w)) similarly for the








As Ξ contains transition rates (from b̃(g(w)), this leads to the stated result upon
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taking νmax → 0.
Extensions
We remark also that Theorem 3.3 would also hold for a slightly more general
branching process. Keeping the transition process as it is, we can have a type x
cell giving birth to j type x cells at a rate α(x)σx,j where for each x, (σx,j)j≥0
is a probability distribution with finite second moment and mean σ̄x. We now
have no need for β(x). In this setting if we redefine λ(x) = α(x)(σ̄x − 1) then
the path distribution will be unchanged. This is due to the fact that the key
result of [47] used in the proof of Theorem 3.1 holds then also. However for
the proofs, the definition of the vector (ψx)
N−1
x=1 in (3.4) should be amended to
ψx = α(x)+
∑
y∈N+(x) ν(x, y). This may be relevant to the case of viral dynamics,
where an infected cell can release multiple virions upon bursting [70].
Throughout we have assumed the population is initiated at the root vertex and
we are interested in the time for a single target population to arise. It may be
of interest to consider several target populations, and then ask which of these
populations arises first. Generally these populations can be grouped together
and the above results will still apply. However if, as in the discussion directly
preceding Section 3.2, we wait for the first individual to arise whose progeny does
not go extinct, a minor modification occurs. For example if we have two target
vertices labelled N1, N2 we should map ν(x,N1) 7→ ν(x,N1)λ(N1)/α(N1) for x a
neighbour of N1 and ν(y,N2) 7→ ν(y,N2)λ(N2)/α(N2) for y a neighbour of N2.
Other numbers of target vertices are treated analogously.
3.3 Applications
We now consider some applications of the preceding section. Firstly we consider
the impact of imperfect drug penetration on resistance. Recently, two theoretical
works have explored how resistance spreads in this setting, and have shown
that poor penetration can accelerate resistance [33, 65]. We are able to recover
and extend the findings of [33, 65]. Next the ordering by which resistance-
causing mutations accrue is explored, firstly in the setting of cancer and then
in bacterial infections. In the case of bacterial infections we explore how the risk
of multidrug resistance depends on mutation rates, recovering simulation results
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in [32]. Underlying the model in each of these scenarios is an acyclic graph,
and therefore we will be investigating these applications with the approximate
formulas implied by the results of Section 3.2.3. These are given in Table 3.1.
Full statement Implied approximate formula






Corollary 3.3 (median time to target) t1/2 ≈ µ+ h(z)






Table 3.1 Approximate formulas implied by the results of Section 3.2 when the
final transition rates are small. b(p), c(p) are again the path benefits
and costs, µ is a simple function of these (see Corollary 3.7) and h(z)
is as given in Corollary 3.3
.
Before continuing to the applications we make a remark on the interpretation
of the approximate formulas. The results of Section 3.2 hold when the final
transition rates in each path tends to 0. Therefore in the present section all
transition rates, in particular the mutation and migration rates discussed below,
will be taken to be small and statements are to be interpreted as approximations
that hold true in this limiting regime. Furthermore, note that the results of
Section 3.2 are given for the case when all transition rates between vertices are
distinct (the limits are taken only on the final transition rates and not on all rates
simultaneously). However below, and in several of the approximate formulas of
Section 3.2, we will take the intermediate rates equal to the final transition rate.
The results of this section could be presented with all transition rates distinct,
and approximations given for when the final transition rates are small but non-
zero. Then the numerical value for intermediate transition rates could be chosen
to be equal to the final transition rates, where for the sake of interpretation they
should be the same. We have chosen to avoid such a presentation.
3.3.1 Imperfect drug penetration: monotherapy
Our first two applications concern imperfect drug penetration and so the language
introduced here shall hold in the next section also.
We consider a pathogenic population, with cancerous cells or bacteria as example
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populations, being treated with one or more drugs with imperfect penetration
profiles. The imperfect penetration results in low drug concentration in spatial
locations, such that cells in these locations may still proliferate. We term the
cumulation of these spatial regions the sanctuary. Sanctuaries have been observed
in both bacterial infections [21, 88] and tumours [71]. We consider resistance to
have arisen when cells with sufficiently many mutations such that all therapies are
impotent come to exist in areas where the drugs have penetrated. The possibility
of resistance occurring prior to treatment is excluded and we consider only the
case when resistance arises from the sanctuary. Further, we do not consider cells
acquiring mutations via gene transfer.
Throughout this section and the next we shall be comparing paths comprised of
mutation and migration events. Growing cells in the sanctuary will be the type
1 cells from Section 3.1.2 and thus have birth and death rates α, β, with growth
rate λ. The lack of exposure to drug motivates λ > 0. We fix the initial number
of cells in the sanctuary to be z. We shall assume all cell types have birth rate
α. Across all cell types, i.e. regardless of location or drug presence, the per cell
mutation and migration rates will be denoted ν and m respectively. We suppose
each mutation carries a fitness cost which will be denoted s. Resistance costs may
not hold always but are well documented and often assumed in viruses, bacteria
and cancer [2, 29, 44]. Migration events bring cells into contact with drugs and
each drug invokes an additive fitness cost d, unless resistance to the drug has
already been acquired. Drug resistant cells outside the sanctuary are the target
type cells of Section 3.1.2 and we define resistance to have arisen when cells of
this type exist. Thus, as there are 4 vertices in this system (i.e. N = 4 see Figure
3.8a) here escaping resistance is defined as {Z4(t) = 0 for all t ≥ 0}.
We introduce the resistance paths and demonstrate the precise effect of the
drug/resistance-mutation costs in tandem. There are two paths from which
resistance might arise, see Figure 3.8a. Firstly, upon replication a cell in the
sanctuary may produce a mutant able to grow in the presence of the drug. Then
a mutated cell in the sanctuary can migrate to the drug compartment. We term
this the mutation-migration path. Analogously we have the migration-mutation
path which involves a susceptible cell migrating from the sanctuary, from whose
progeny a mutant emerges. Due to the fitness cost of resistance, the death rate
of mutated cells in the sanctuary is increased to β + s, while the death rate of
migrated susceptible cells in the drug compartment is β + d, with s, d > 0.
The first quantity to determine is the probability of escaping resistance (drug
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resistant cells outside the sanctuary never exist), and its dependence on the initial
number of cells in the sanctuary. The approximation of (3.17) shows that the
probability of resistance never occurring decreases exponentially with the initial
number of cells in the sanctuary as P(resistance never occurs) ≈ (β/α)z. For the
rest of the discussion we will assume resistance does occur. Further we suppose
z  1, so that we may use the approximate form for h(z) given in Corollary 3.3.
The case when z is small could be treated similarly using the exact expression
for h(z).
Let t1/2 be the median time until resistance occurs. Then from Corollary 3.3 we
immediately have















As expected increasing the resistance cost or drug efficacy increases the resistance
time, while increasing the initial sanctuary speeds up resistance. This simple
result can now be explored under different biological scenarios.
For example, suppose we are currently using drug A with fitness cost d(A) and
penetration profile leaving z(A) initial cells in the sanctuary. We consider instead
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1/2, and hence we should






This inequality is illustrated in Figure 3.8b.
Note as δd → 0, implying drug B is far more effective, the condition tends to
δz > (1 + s/d
(A))−1. This is due to the fact that when d(B) is large resistance
will always arise via the mutation-migration path (which we show below), so
this provides an upper bound to the gain that can be obtained from increasing
the drug efficacy. The above is under the assumption resistance will occur but


























(a) In the case of monotherapy, there
are two paths by which drug resis-
tance cells can arise in the region
containing the drug. Horizontal
edges represent changes in genotype
(gaining resistance) whereas vertical
edges represent changes in spatial
location. The values of vertices are
the fitness cost cells experience in that
state.
























(b) Comparison of two drugs with differ-
ing efficacies and penetration profiles
using (3.29). Arrows pertain to
characteristics of drug B relative to
drug A. Top left and bottom right
quadrants, inside dashed lines, illus-
trate region where drugs are trivially
better, i.e. have superior penetration
and efficacy. Parameters: d(A) =
10−2, s = 5× 10−3.
Figure 3.8
sanctuary size.
Having discussed the time for resistance to occur we now ask by which of the two
paths it will occur. Let T νm be the first time resistance arises via the mutation-
migration path and Tmν be defined analogously for the migration-mutation path.
Then Theorem 3.3 gives us
P(T νm < Tmν) ≈ (1 + s/d)−1.
It is reassuring that as s → 0, and therefore no cost is associated with the
mutation-migration path, this path is taken with probability 1. Generally
resistance arising via the mutation-migration path is more probable, i.e. the
above probability is greater than 1/2, if d > s. We naively expect this condition
to hold for most drugs.
A similar question was asked in [33]. There the authors considered an
approximate stochastic process and sought the parameter regime such that Tmν
stochastically dominated T νm under the approximate process. For the full process
considered here, we can ask the same question but on the limit of the centred, in
the sense of Theorem 3.2, resistance times. The resulting condition for stochastic
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dominance is again d > s. The discrepancy in the condition given here and that
stated in equation (28) in [33] exists as there ν is defined as the probability of
mutation per birth event. Accounting for this leads to the same condition.
3.3.2 Imperfect penetration: combination therapy
There are at least two reasons for extending our analysis to include two drugs, say
drugs A and B, being used in tandem. Firstly, combination therapies are widely
implemented in both cancer and bacterial infections. Secondly, interesting new
phenomena emerges, especially when a region still exists with only one drug
present. This represents the scenario where one of the drug’s penetration profile
is a strict subset of the other.
We will only consider the case where the penetration profile for drug B is a
subset of drug A, and thus a single drug region exists only for drug A. This
allows us to clearly demonstrate the impact of unequal penetration profiles. In
this setting there are 12 possible states that a cell may inhabit, defined by which
of the drugs the cell is exposed to and the resistance it has obtained. These states
are illustrated in Figure 3.9a. A more general case can be treated similarly. We
further assume that the mutation rate bringing resistance to either drug is ν.
This is for simplicity only, and having differing mutation rates is straightforward.
Drug interactions and epistasis are also neglected but can be included.
To investigate the effect of the single drug region, we introduce further notation.
Let nTot be the number of cells that may reside in our system of interest (e.g.
the entire patient or tumour) in the absence of drug. Further, let the regions
where both drugs act, the single drug (drug A) acts and the sanctuary have
their respective cell capacities denoted by nDD, nD, and nS. We assume that all
these capacities are large, and hence we may still investigate the system with
our branching process model. These capacities enter the dynamics of the process
in the following manner. When a cell leaves the region it is in, at rate m, it
now may migrate to one of two regions. Of these two regions, we specify that
it migrates to a particular region at a frequency proportional to the region’s
capacity. For example a cell in the sanctuary migrates to the double drug region
at rate mnDD/(nD + nDD). The form of this migration rate can be motivated
by assuming cells migrate via the vascular system, and that the interface size
between particular regions and blood vessels is proportional to the capacity of
those regions. It is also the form assumed in [65] which allows comparison with
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Drug A & B
(a) Illustration of the paths to multidrug
resistant cells arising in the region
containing both drugs A and B, as in
Figure 3.8a. Note a spatial location
exists containing only drug A. The
path benefits and costs for the red-
dashed path are given in (3.30).
(b) Exploration of the median time to
resistance as the relative size of the
region containing only drug A to the
sanctuary increases. A single drug
region can speed up resistance when
(3.31) holds. When true, resistance
is fastest at nD/nS ≈ 0.6, agreeing
with (3.32). Parameters; (top) ν =
10−6, m = 0.05, d = 0.9, s =
10−3, λ = 0.4, α = 0.3, nTot =
107, nDD = 0.9nTot, γ = 10
−3;
(bottom) all same except s = 10−2.
Figure 3.9
their results. If, instead, one wished to replace the regions’ capacities with the
volume or surface area, the results below would not differ, only the interpretation
of the initial sanctuary size. Resistance mutations and the presence of the drug
has the same additive effect as in Section 3.3.1.
Observe that, when all compartments have positive size, there are 18 possible
paths. To see this, it is convenient to separate the paths into those that pass
through the single drug compartment, which following [65] we term stepwise
evolution, and those that involve migration from the sanctuary directly to the
double drug compartment, which we collectively call direct evolution. For the
direct evolution paths there are three transitions needed, mutations to drug A
and B and then the migration to the double drug region. From the number of
permutations of these events, this yields 6 direct evolution paths. In the stepwise
evolution case four transitions are needed, both mutations and then the two
requisite migration events. Notice that the migration from the sanctuary to the
single drug region must precede the migration from the single drug region to the
double drug region. This leads to 12 stepwise evolution paths.
An exemplar stepwise evolution path is a mutation causing resistance to drug A,
followed by migration to the single drug region, then a mutation causing resistance
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to drug B, and finally a migration to the double drug region. The edges of this
path are red and dashed in Figure 3.9a. As before, the path benefits and costs
are important. If we denote our exemplar stepwise evolution path, path 1, then






, c(p(1)) = 2s3. (3.30)
Note that d does not feature in the cost as resistance is always acquired prior
to migration. The ordering of mutations matters for stepwise evolution paths,
as acquiring resistance to drug B prior to migration does not negate the cost of
exposure to drug A. We also observe that the path benefit given above will be
the same for each stepwise evolution path.
Next we consider the biologically motivated scenario in which the size of the
single drug region comes at the expense of the sanctuary. A trade-off may exist
between reducing the initial number of proliferating sanctuary cells and increasing
the number of paths to resistance. To study this we let r = nD/nS, fix nTot =
nS + nD + nDD, and specify that the initial number of cells in the sanctuary is
related to its size via z = γnS with 0 < γ  1. Further let t1/2(r) be the median
time to resistance with fixed r. Using the approximation provided by Corollary
3.3 we can explore the behaviour of t1/2(r). As can be seen in Figure 3.9b it is
possible that the existence of the single drug compartment speeds up resistance.
We now seek the conditions under which this is the case.
It is reasonable to expect that the efficacy of either drug is greater than the cost
to resistance. Also we may hope that both drugs penetrate the majority of the
target system. This motivates taking s  d and (nS + nD)  nTot. Under this
limit, by examining the sign of d
dr
t1/2(0), we find a simple condition for when







However, when (3.31) holds, due to depletions in the sanctuary size, as nD/nS
increases eventually a minimal resistance time is achieved. This represents a







We now examine whether resistance arises via stepwise evolution or direct
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evolution. Let TSE be the first time resistance occurs via stepwise evolution,
and TDE defined analogously for direct evolution. Then using Theorem 3.3, again
with s d, we find







Therefore the larger the proportional size of the single drug region, the more
likely resistance will arise via stepwise evolution. A qualitatively similar result
was derived in [65] (e-page 2878) by comparing the most likely stepwise evolution
path with the most likely directed evolution path.
Furthermore, in [65] a minimal resistance time, in the sense of (3.32), was observed
via simulations for the mutationA-migration-mutationB-migration path (path 1
from (3.30)). Using Theorem 3.3 we can show that this is the most probable (in
the sense of the mode of the path distribution, see (3.24)) stepwise evolution path
whenever d > s. Further, by differentiating the median time along this path, we
see a minimal time occurs at nD ≈ nS, which recovers the simulation result in
[65] (Figure 3). That this path is the most probable stepwise evolution path also
gives insight into the recurring s/m term in (3.31) and (3.33). Relative to direct
evolution this path has an extra migration step, so higher migration should be
beneficial. However fitness costs along this paths are incurred only via the cost
of resistance, and a smaller s diminishes these fitness costs.
3.3.3 Path to resistance in chronic myeloid leukemia
We now consider the example given in [57], concerning the mechanism by which
resistance to the targeted therapy imatinib occurs in chronic myeloid leukemia
(CML). The two main resistance mechanisms are via gene amplification of the
BCR-ABL fusion gene, which drives the CML, or a point mutation resulting
in a modification to the target protein of imatinib. Approximately 100 point
mutations have been identified that confer resistance, and a rough estimate for
the probability of each of these occurring during a cell division is 10−7 [61]. Thus
the probability of a point mutation conferring resistance is approximately 10−5
per division. The analogous quantity for resistance-causing gene amplifications,
in a similar system, was found to be approximately 10−4 [83]. With the birth rate
of leukemic stem cell as α = 0.008 day−1 [63] we have the rate of point mutations
as νpm = 8× 10−8 days−1, while the rate of resistance due to gene amplifications
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is νga = 8× 10−7 days−1. Therefore, using this information alone, the probability
of resistance arising from a point mutation first is estimated to be 1/11. However,
in the majority of cases, the primary mechanism of resistance is found to be point
mutations [11].
Within our framework there are two possible explanations we can consider, both
related to the reproductive capabilities of resistant cells. The first is simply
that more lineages of amplified cells go extinct. The comments following (3.1)
indicate how to treat this case. Indeed, if ρpm is the average survival probability
for a population initiated by a single cell with a point mutation and ρga the
analogous quantity for gene amplification, then we find resistance arising first
from a point mutation is more probable if ρpm > 10ρga. This is possible as point
mutations may be deleterious or advantageous [61] whereas gene amplifications
appear deleterious [82].
The second explanation, that suggested in [57], is that several gene amplifications
are required to attain resistance. Suppose a gene amplification increases the death
rate of cells by s per day. Then if two gene amplifications are required, ignoring
the survival probability from before, the probability that resistance arises via
point mutation is now
νpm
νpm + ν2ga/s
= (1 + 8× 10−6/s)−1.
Resistance via point mutations is now more likely if s > 10−6. Further
explanations for the primacy of point mutation mediated resistance exist and
the assumptions above may not hold. But when they do hold, our results offer a
clear framework to investigate such questions.
3.3.4 Antibacterial multidrug resistance
We now move to consider multidrug resistant bacteria. As before we assume
resistance incurs a fitness cost and thus the (unmutated) wild-type has the highest
growth rate. Using Theorem 3.3 and measured fitness costs and mutation rates
we can predict the most likely path to multidrug resistance.
We consider the acquisition of resistance to both rifampicin and streptomycin in
P. aeruginosa. Recently the fitness costs associated with resistance to rifampicin
[39] and streptomycin [87] have been reported. Fitness costs were determined
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by the maximum growth rate of the bacteria undergoing exponential growth on
media-rich plates. From [87] the ratio of streptomycin resistant bacteria to the
wild-type’s growth rate was 0.71 (here the wild-type’s growth rate is estimated
to be 5.1 mOD min−1 from Figure 2.a in [87]). The same value for resistance to
rifampicin, in [39], was 0.88. Let TRS be the first time of multidrug resistance
when rifampicin resistance is acquired first, and T SR defined analogously for
streptomycin resistance first. Then from Theorem 3.3, we have that
P(TRS < T SR) ≈ 1− 0.71
(1− 0.88) + (1− 0.71)
= 0.7.
We note that above we have taken the average fitness costs associated with the
differing antibiotics. Fluctuations have not been taken into account.
Instead of considering the differing mutation rates to different drugs within a
bacterial strain, we can also examine the impact of differing mutation rates across
strains. In [32] the heightened occurrence of multidrug resistance in lineage
2 vs lineage 4 from M. tuberculosis was considered. Considering in particular
resistance to rifampicin and isoniazid, via simulations the authors deduced that
the heightened occurrence of resistance was due to elevated mutation rates
in lineage 2 strains. The model simulated can be considered a discrete time
counterpart to ours in the case of two paths of length 2. One of the main quantities
of interest was the relative probability of resistance, when the only difference
between the strains was greater mutation rates. For a particular strain, initiated
with one wild type cell with wild-type birth and growth rates, α, λ, suppose we
have mutation rate νR, νI to rifampicin and isoniazid, each incurring the same
fitness cost s. Then from Theorem 3.2, we have
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have the relative probability of resistance
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I . Taking the mutation rates measured in [32], this gives
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the relative probability of 22.06, which agrees with the simulation results in [32]
(an approximately 22 fold increase is reported on page 788, and indicated on
Figure 2c in the supplementary information). If in (3.34), we replace the λ2/α
with λ and eλt with M , our expression is the same, to leading order in the
mutation rates, as that given in [18] (equation 2) for the probability of resistance
in a population of size M . This difference between fixed population size and fixed
time results is the same as given in [16, 27].
3.4 Discussion
3.4.1 Shortcomings and future work
There are several shortcomings with the work presented in this chapter which we
now discuss. We first consider those shortcomings arising from our reliance on
the almost sure convergence of the growth of intermediate populations detailed
in Theorem 3.1.
Firstly, our approach of always taking the final transition rates in the path to zero
is rather unwieldy. As noted at the beginning of Section 3.3, we cannot rigorously
cover the setting when the intermediate transition rates are equal to the final
transition rates. Secondly, for a similar reason we cannot treat transitions that
do not occur at replications, i.e. leave behind a cell of the original type. If this
were to be the case then altering the final transition rates would affect the growth
of the penultimate population type. This criticism is relevant in the scenario of
migration treated in Sections 3.3.1, 3.3.2, as it is unlikely a migrating cell would
do so upon replication. However if the migration rate is small, the dynamics
of the penultimate population is unlikely to differ greatly. Hence we expect the
above conclusions to broadly hold. Finally, while the assumption that the type
1 population is the most fit is often biologically motivated, it cannot easily be
relaxed as then λ would cease to be the dominant eigenvalue of the matrix A
from Section 3.2.1. The case where each transition leads to an increase in fitness
was treated in [27], and a merging of the results given there with those presented
here should be possible. This is left for future work.
In this chapter we considered the first time the target population arose and
possibly the most straightforward extension would be to characterise the sequence
of initiation times, as opposed to only the first, that is the Cox process of
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immigrations to the target. Under the same centring as Theorem 3.2, we would
expect the entire process to converge. For the case of N = 2, i.e. a two-type
process, this was carried out in [16] and the same method should apply here.
As in Chapter 2 a possible extension is to consider the case where the fitnesses of
types are themselves random variables. This is due to the observed fluctuations
in fitness in both cancer [61] and bacteria [39]. So long as the type 1 is the most
fit with probability one, the formulas presented in this chapter would then be the
conditional results of the more general model.
In terms of biologically applicability, as with all branching process models with
constant parameters, the exponential growth of the population is ultimately
unrealistic. It would be interesting to know to what extent the features discussed
above hold for populations with a large carrying capacity. The time scale to
cross a fitness valley is given by the variable µ but this differs from the time scale
observed in [36]. However there a carrying capacity of 100 was used. Carrying
capacities were also used in [65] of the orders 105− 107 and we have been able to
derive analytic expressions matching their simulation results, see Section 3.3.2.
We would speculate that the carrying capacity should be large enough such that
the target vertex is populated before the type 1 population saturates. This also
implies the transition rates must be large enough also. A full investigation of this
is also left for future work.
3.4.2 Concluding remarks
In this chapter we have considered a continuous time birth-death process with
transitions. The time until the population of a particular target type arises was
studied. This population type is accessible via one or more transitions from
the initial population type. Which sequence of transitions leads to the target
population arising was explored. This gave rise to a probability distribution
over the paths composed of transitions between differing types. Motivated by
applications, the setting when the initial population was most fit was focused on.
The important factor in determining whether the target was reached via a specific
path was seen to be the path’s benefit and cost. These terms are comprised
of the transition rates and fitness costs associated with the intermediate types
along the considered path. Both the time and path distribution have simple,
explicit formulas. The utility of these formulas was demonstrated on a variety of
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applications. The biological relations revealed might have been difficult to deduce
by a simulation based approach.
Justified criticisms have been made on the use of birth-death processes as a
modelling framework. In particular the potential for unlimited growth and lack
of interactions between cells is unrealistic. However in systems with large carrying
capacities and abundant resources, they provide a convenient approximation and
are widely used. If this framework is deemed appropriate, this chapter provides





At the outset to to this thesis, we outlined the importance of mathematical
models concerning populations seeding further populations. These models have
a diverse range of applications [1, 56, 62, 66] and are generally simple to state
and intuitively motivate. However despite their apparent simplicity and impact,
many aspects of these fundamental models remain unexplored. While several
applications have been considered in the previous chapters, a fuller understanding
of the models themselves was the driving motivation for this work.
Inspired by the success of Lea and Coulson [60], Chapter 2 explored a generalisa-
tion of their model, where stochastically growing mutant clones are initiated by a
deterministically growing wild type population. It should be kept in mind that if
stochastic wild type growth is desired, then Chapter 2 concerns clones conditioned
on wild type growth. How differing wild type growth manifests itself in the
clone size distribution was investigated. In some sense the intuition gleaned by
considering deterministic mutant growth (Section 2.1.4) provided the take home
message. Clones seeded from faster growing populations are more likely to arrive
later in the process and so, on average, will be smaller. However the dichotomy
that was demonstrated regarding clone sizes seeded from subexponential versus
exponential-type wild type growth would have been difficult to predict a priori.
Our application of choice was the scenario of a primary tumour seeding
metastases. From our theoretical results it was predicted that regardless of the
primary tumour growth, a power law tail was expected in the metastasis size
distribution. As a first step to explore this, likelihood analysis was applied to a
dataset of metastasis sizes. The power law hypothesis was found to be plausible.
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Moreover the estimated exponents of how the power law decayed in the empirical
metastasis distributions gave a point estimate of the relative growth rate of the
metastases to the primary tumour. This point estimate suggested the metastases
grew faster than the primary, which is consistent with previous findings.
We next turned to the setting of a target population arising which might require
multiple transitions from the original population. The questions of how long
we wait until a target cell type exists and which sequence of intermediate types
initiated the target population were considered. Our primary contribution here
was to provide relatively simple, malleable formulas in terms of the path benefit
and costs as answers to these questions. The formulas are intuitively appealing
and amenable to further analysis. The applicability of these formulas was
demonstrated in a variety of scenarios including exploring the impact of imperfect
drug penetration, and how the ordering of mutations depends on fitness costs and
mutation rates.
It may be argued the results of this thesis are special cases of more general results
found in the branching process literature. However our aim here is to explicitly
focus on those special cases which have biological significance, examining the
biologically pertinent aspects and then reinterpreting our findings in light of
the application. The transition of the statement of Theorem 3.2 in Chapter 3
to its application in Section 3.3 is a prime example. The original statement
contains the entries of a given eigenvector of a given matrix. While for any
set of parameter values this eigenvector may be obtained numerically, it is by
considering their representation in terms of path benefits and costs that leads to
a greater understanding of the process, and in turn the biology.
This last example illustrates what we hope this thesis contributes. If biological
scientists wish to model a particular system, and if their model of choice is related
to the models considered above, then the work presented here might be used to
enhance their toolkit and give a firmer grounding to their intuition.
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Appendix A
Appendix to Chapter 2
A.1 Special functions and definitions
Required definitions and identities taken from [26] unless otherwise stated.







Note that Li1(z) = − log(1 − z). Gauss’s hypergeometric function also appears














for |z| < 1,
and by analytic continuation elsewhere. Here (a)k denotes the Pochhammer
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, (A.3)









= Bz(a, b) =
∫ x
0
ta−1(1− t)b−1 dt. (A.4)
A.2 Exact time dependent clone size distributions
Here we derive the generating functions for the clone sizes given in Table 2.1
and the notation here is as given in Chapter 2. Where possible we also give
expressions for the probability mass functions.
A.2.1 Exponential wild-type growth
We start with the case of exponential growth, nτ = e
δτ with δ > 0. The
distribution for the total number of mutants, Bt, was treated exhaustively in
[51] and we follow their notation by letting γ = δ/λ. Using (2.5) and the results
found in section 3 of [51], the generating function is



















Similarly the mass function is


















and for k ≥ 1










































is Gauss’s hypergeometric function and (a)k is the Pochhammer
symbol defined in Appendix A.1. The above expressions are given in terms
of nt to allow easy comparison to the formulas in [51]. For these exact time-
dependent formulas, their form is somewhat cumbersome, however simpler long-
time limit expressions are given in Section 2.3.1. A reduction in complexity is
also obtained for the special case of neutral mutants (δ = λ) where, by using
(A.3), the generating function in (A.5) simplifies to







If additionally the neutral mutants are immortal, the above expression further
simplifies to
Yt(s) = 1 +
1− s
sφ
log(1− sφ) where φ = 1− e−δt.
The probabilities are then concisely given by






or P(Yt > k) =
φk
k + 1
which corresponds to the classical Lea-Coulson result [60]
Bt(s) = (1− sφ)θ(1−s)/s
with θ = νeδt.
A.2.2 Power-law wild-type growth
Now we assume that the wild-type population grows according to a general power-
law nτ = τ




































where Lii(s) is the polylogarithm of order i defined in Appendix A.1. This may
be derived by a binomial expansion of the denominator and an identity for the
incomplete gamma function, but for succinctness we differentiate both sides with
respect to τ . First we note that
z∂zLii(z) = Lii−1(z).
















= τ ρ(1 + Li0(ξe
−λ(t−τ)))
where the equality follows by the telescoping nature of the sums. Noting that




+ 1 and applying the limits of the integral
reveals the generating function to be











To determine the mass function, we seek a power series representation of the
generating function. We focus on the β = 0 case and thus ξ = s
s−1 . By the



















































































yields the mass function
































If mutants may die, the exact mass function is most easily obtained via Cauchy’s
integral formula which may be efficiently computed using the fast Fourier
transform. For a brief discussion on implementation see [4] and references therein.
Note for ρ ≥ 1, n0 = 0 which, while useful for analytic tractability, is unrealistic.
This can be overcome by letting nτ = n0 + τ
ρ. Then, by splitting the integral
in the generating function (2.4) and using the above analysis, one can obtain the
mass function for any n0. However for practical purposes the contribution of n0
is negligible.
A.2.3 Constant size wild-type
For the specific power-law growth when ρ = 0, i.e. nτ = 1 (recall that this is
equal to the general case when nτ = n0), we recover some classical results for
constant immigration [52]. We note that the distribution of the ordered clone
size, depending on initiation time, was discussed in [48]. From (A.7) with ρ = 0,










with St as given in (1.6). By expanding this generating function in terms of s we
obtain the probabilities
P(Yt = k) =
1 + t−1 log(1− S−1t ) k = 01
tαk
S−kt k ≥ 1.
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Then using (2.5) with the clone sizes (A.8) we obtain the generating function of







and from the binomial theorem we also get the probabilities








We recognise this as a negative binomial distribution under the interpretation
that Bt is the number of failures until ν successes, with failure probability S
−1
t .
This result for Bt was first derived by Kendall [52] who was attempting to
explain the appearance of the logarithmic distribution for species number when
randomly sampling heterogeneous populations, conjectured by R.A. Fisher. From
the distribution of Bt, by an argument which may be considered a special case
of Proposition 2.1, he derived that for constant rate initiation, the clone size
conditioned on non-extinction is logarithmically distributed again with parameter
S−1t , which can be obtained via (2.7).
Constant immigration may imply a constant size source, hence mutants with
equal birth and death rates (i.e. evolving as a critical branching process) are
particularly interesting. This case yields analogous formulas to those above but
St is replaced with the expression given in (1.7).
A.2.4 Logistic wild-type growth
Starting from a population of one and having a carrying capacity K, logistic
growth is given by nτ =
Keλτ
K+eλτ−1 . We assume neutral mutations, i.e. λ is also the







We aim to calculate the generating function using (2.4). Recalling the definition













Therefore the generating function is
Yt(s) = 1 +
λeλt









Agreeing with intuition for K = 1 we recover the generating function of the
constant case, and limK→∞ Yt(s) gives the generating function for exponential
wild-type growth. Therefore the logistic case interpolates between the constant
and exponential growth cases. The mass function can be obtained by expanding
the non-logarithmic and logarithmic function in Yt(s) and using the Cauchy
product formula. However, this method provides little insight and numerically it
is simpler to use the fast Fourier transform.
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Appendix B
Appendix to Chapter 3
B.1 Topological sorting of a directed, acyclic
graph
In this short appendix we show that for a directed acyclic graph, a relabelling of
the vertices exist such that the adjacency matrix of the relabelled graph is upper
triangular. This labeling is often called the topological sorting [19] (chapter 22.4).
Lemma B.1. If G = (V,E) is a simple, finite, directed acyclic graph (DAG)
then G contains an element with in-degree 0.
Proof. Suppose not. Then take any v ∈ V . There exists (u, v) ∈ E for some u ∈
V . This may repeated indefinitely. Hence due to finiteness we have constructed
a cycle, yielding a contradiction.
Lemma B.2. For a DAG, we may label the vertices v1, . . . , vn, with n = |V |,
such that for all (vi, vj) ∈ E we have i < j.
Proof. Take a vertex with in-degree 0, which exists by Lemma B.1, and label this
v1. Let G1 = G. For k = 2, . . . , n, consider the subgraphs Gk = Gk−1 − {vk},
where we choose vk−1 to be a vertex with indegree 0 from Gk−1. Such a vertex
will exist as all Gk are still DAGs. Under this labeling, suppose (vi, vj) ∈ E
with j < i. This implies at step k = j in the above construction, vj has positive
indegree, which contradicts the above construction. Hence the result.
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